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ABSTRACT
Experimental studies were performed to fabricate various material structures using genetically
engineered M13 bacteriophage. This virus template showed superior controls of material
syntheses from nanoscale to microscale. Structures including nanowires, nanoparticle arrays,
hetero-particle arrays, and micro-fibers were fabricated using the engineered MI3 virus as the
building block and mineralization platform. The mineralization mechanisms were revealed by
alternating the types and amounts of peptide motifs displayed on the viral templates. The results
showed the importance of a fused peptide motif to mediate the mineralization process of a
material, which was dominated by either physical absorption or chemical nucleation. The
potential applications of the materials synthesized using the viral template, including energy
generation and biosensors, were also demonstrated. For the first time, several types of highly
engineered MI 3 virus were used to fabricate nanostructures such as nanowires, nano-arrays,
hetero-particle arrays, and complex nanowires. A type 8 phage library was reported to screen
peptide motifs for making nanowires. A multi-functionalized viral template, type 8-3 virus, was
engineered and demonstrated to create a variety of nano-archietetures. A type 8+8 virus was used
to create complex nanowires embedded with different materials. In addition, the mechanical
properties of virus-based materials were evaluated and characterized for the first time. The
tunable functionalities and mechanical performances of virus-based materials showed promising
capabilities not only to manipulate material syntheses and structures but also to be integrated
with other synthetic materials using current processing techniques.
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Title: Germeshausen Professor of Materials Science and Engineering and Biological Engineering
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Chapter I. Introduction
I.A. Motivation
Nature has developed remarkable controls and means of material syntheses and
fabrications for various applications. Nature's engineering is truly amazing. We have
observed beautiful archetictures, strong materials, and even functional devices from
natural products. Nature precisely constructs complicated but well-organized material
structures from nanometric through micormetric to metric scales. One of the examples is
the structure of diatom (Figure 1). Diatom is a type of eukaryotic alga and unicellular
plankton. The cell wall of diatom is made of silica ' , and the structure of silica is highly
ordered and hierarchically constructed on the cell. Another example is the abalone shell
(Figure 2). The shell of abalone is made of calcite 3- . The mechanical strength of the
abalone-made calcite is hundred times stronger than its geological counterpart. The
reason why it can be so strong is because of the nanostructured and highly ordered
crystallized calcite assembled into the shell. Another example is the magnetotactic
bacterium (Figure 3). It mineralizes magnetite in the membrane organelle called
magnetosome and secretes a chain of magnetite particles aligning inside the cytoplasm6 .
The magnetotactic bacterium exhibits a special ability to align itself in the direction of the
earth magnetic field. It is believed that this bacterium is using the magnetite to navigate
itself. From these examples, it is not hard to find that nature can produce various
organized, strong and functional materials.
If we trace the synthetic or fabrication routes to see how nature makes these terrific
materials, it may end up to find that all these natural structures, components, and
functionalities are originally governed by the molecule, DNA. This fabrication
mechanism is not only simple but also complicated. It is simple, because DNA only has
four types of bases with single type of molecular backbone (sugar and phosphate). It is
also complicated, because DNA derives into 20 amino acids, which are the structural
units of proteins. Thousands of combinations of the amino acids produce millions of
different polypeptides, and hundreds of posterior modifications on the polypeptides are
executed by nature to make various proteins. Millions of organelles, cells, creatures and
species are therefore created.
From the viewpoints of chemical engineering, I am intrigued by the accuracies of
controls on the material syntheses by manipulating a few parameters, the four bases in
DNA. From the aspects of materials science and engineering, I am interested in
understanding and extending the advantages of these naturally evolved and developed
fabrication techniques. How can people use or mimic the natural routes to make various
materials that are useful for contemporary material's world, e.g. fabricating nanowires for
electronics or producing fibers for functional clothing?
I.B. Scope of Work
This work was focused on using natural templates to create nano- and
micro-materials of interesting structures, properties and functionalities. From the route
that nature has developed to synthesize materials, proteins are the mediators between the
constructing instructions (i.e. DNA information) and the final products (e.g. abalone
shell). Proteins are used as the building scaffolds to construct and assemble various
components into natural products (Figure 4). There are a lot of choices of bio-organisms
potentially can serve as biological templates to manipulate the syntheses of materials. In
this thesis, M13 bacteriophage was chosen as the research tool to demonstrate the
intelligent designs and controls of material fabrications by manipulating the genome. The
filamentous structure of M13 bacteriophage provides a low-dimensional building block,
one-dimensional nano-filament, of nanometer scale. Ranging from nanometric to
micrometric scales, the exploitation of precise controls on the expressions, conformations,
and functionalities of the bacteriophage building block were demonstrated, and the
characterizations and applications of the materials fabricated using the M13
bacteriophage were examined and discussed in the thesis.
I.C. Figures
Figure 1. Hierarchically and highly organized silica (Si0 2). Diatoms, unicellular
planktons living in the sea. Their cell walls are made of silica through highly organized
biomineralizations. (Daniel Morse, UCSB)
Figure 2. Tough calcite (CaCO3 ). The abalone shell is comprised of layers of
crystallized calcite. Between two calcite sheets is a layer of proteins serving as adhesives
to hold the structures and platforms to mineralize calcite. (Angela Belcher, M.I.T.)
Figure 3. Functional magnetite (Fe30 4). A magnetotactic bacterium secretes magnetite
nanoparticles in the periplasmic space and aligns these nanoparticles inside the cytoplasm
to serve as guiding devices. (Arash Komeili, UC-Berkeley)
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Figure 4. Fabrication lines of natural and artificial materials. New types of synthetic
materials can be fabricated through mimicking natural processes and utilizing natural
templates, providing outstanding molecular controls at different scales.
Chapter II. Biologically engineered toolkit and preliminary
identification of peptides
II.A. Summary
M13 bacteriophage is a well-known filamentous virus. Its whole genome has been
revealed and studied for years. It is a non-lytic virus and harmless to mammalian cells.
The capsid protein groups on a viral particle can be independently altered by engineering
the viral genome. The ease to modify and engineer the M13 bacteriophage makes this
virus a powerful biological toolkit. The dimensions and functionalities of a virus can be
precisely and simply controlled by manipulating the genome. Unlike the other biological
molecules such as protein and DNA serving for templating applications, biological
organisms such as M13 viruses have precisely defined structures. Its programmable
protein functionalities promise the ultimate flexibility in assembling hetero-functional
nanostructures, which makes this viral system an attractive template for synthesis and
assembly of various materials and structures. M 13 bacterioaphge can be used not only to
serve as the templating material for nanotechnology but also to create peptide libraries for
biological applications. By displaying random peptides on a certain group of proteins on
the bacteriophage, a phage display library can be constructed. Phage display library is the
pool of bacteriaphages contains millions of random peptide sequences. A peptide motif of
interest to target a specific material is acquired through the evolutionary screening
process, biopanning. To select peptides for targeting materials of interest, type 3 phage
display libraries are commonly used. However, a peptide selected from a type 3 library
may not function correctly when it is expressed on a different type of protein. Therefore,
to obtain effective functionalities on the bacteriophage surface, it is essential to design
suitable peptides for different types of coat proteins. In this chapter, the methodologies
used to select functional peptide motifs and to engineer the viral templates will be
discussed. Besides, the type 8-3 engineered virus for hetero-architectures and the type 8
library for biopanning and biomineralization were reported for the first time.
II.B. Introduction
M13 bacteriophage
M13 bacteriophage (or virus) is a type of filamentous virus. The dimensions of M 13
bacteriophage are 880 nm in length and 6 to 7 nm in width, giving a high aspect ratio of
about 150. The length of this virus is determined by the size of viral DNA
(deoxyribonucleic acid), which is about 6,400 nucleotides long for a wild-type strain.
M1 3 bacteriophage has a circular single strand DNA (ss-DNA) enclosed in a cylindrical
capsid. The DNA encodes 11 genes for a wild-type M I13 virus. The viral DNA stores all
the information for signaling the bacterium host to produce various proteins, including
DNA replication proteins, capsid proteins and assembly proteins. Figure I shows a
commercialized DNA vector of M13 bacteriophage. The first group of genes, II, V, and
X, producing proteins are required for the replication, transportation and folding of the
viral DNA. The proteins produced by the group of genes, III, VI, VII, VIII, and IX,
constitute the cpasid proteins of the bateriophage particle. The last group of genes, I, IV,
and XI, produces proteins involving in packing the capsid proteins onto the viral DNA to
form bacteriophage particles.
The capsid of the virus is comprised of approximately 2,700 copies of the major coat
proteins pVIl1, capped with about 5 copies each of minor proteins pill and pVI at one end
of the bacteriophage, and about 5 copies each of minor proteins pVII and pIX at the other
end. A summary of these coat proteins is listed in the Figure 2. pVIII is the most
abundant capsid protein, which is helically packed around the long axis of DNA in a
right-handed way (Figure 3). X-ray diffraction and other studies have given well
descriptions of the structure of pVIllII protein' 9. It exhibits an uninterrupted alpha helical
conformation except for the first five amino acids from the N-terminus (Figure 4). pV1I
and pIX are hydrophobic proteins. The arrangement of these proteins at one end of the
capsid is still unknown. pIII and pVI proteins assembled on the other end of the capsid
account for 10-16 nm of the bactiophage length. pIII protein is the largest coat protein
(about 400 amino acids) in the capsid (Figure 5). It is a globular protein and an essential
region for the infection process of virus10' 11
The amino acids of these coat proteins residing at different locations on a viral
particle can be rationally altered independently via genetic engineering.12 The
methodology to express peptides or proteins on these coat proteins is so called phage
display. It is a powerful new technique for carrying out molecular evolution in the
laboratory. The display of peptides or proteins on the surface of bacteriophage is
achieved by cleaving and recombining DNA fragments through the restriction sites in the
viral DNA. The programmable capability and its inherent structural advantages promise
the extraordinary flexibility in assembling nanostructures, which makes this viral
template an powerful engineering stytem for synthesis and assembly of various materials
and architectures.
Modifications of Ml 3 bacteriophage
Various types of vectors are commercially available for peptide fusions on the
surfaces of M I3 bacteriophage particles. Through standard molecular biological methods,
more enzyme restriction sites can be introduced into the viral vector for the convenience
of genetic engineering, and therefore various types of phage displays can be achieved.
Viral vectors that display fusions in genes III and VII are termed type 3 and type 8.
Bacterial cells carrying these type 3 or type 8 vectors will assemble the virus particles
with 100% identical and recombinant pIll or pVllI coat proteins, respectively. In another
amplification system, two independent vectors are introduced into a bacterial cell for
producing two different pill proteins (or pVlll proteins) simultaneously. One vector is
phagemid vector, which carries a copy of either gene Ill or VIII but does not have the
groups of genes for the assembly of bacteriophage. The other vector is M13 viral vector
(referred as helper vector or helper phage), which encodes the full genes (including
wild-type gene VIII) for virus amplification. When a bacterial cell harboring the
phagemid vector is infected by M13 bacteriophage (helper phage), the amplified
bacteriophage particles will carry a mixture of wild-type (from helper phage) and
recombinant (from phagemid) pIII or pVIII proteins. 13' 14 The bacteriophages produced
using the phagemid system are termed type 3+3 or 8+8. Other types of virus structures
such as type 33 and type 88 theoretically could be achieved through genomic
modifications. In this thesis, type 3, type 8, type 8+8, type 8+8-3, and a new type 8-3
phage are used and engineered (Figure 6). Type 8-3 has two distinct peptide motifs
displayed on pIII and pVIII proteins. And, type 8+8-3 has two types of pVIII proteins and
one type of pIII proteins assembled on the bacteriophage particle.
Recombination and transformation
A M13 bacteriophage particle contains a single-strain deoxyribonucleic acid
(ss-DNA), which encodes all the information to replicate the viral DNA itself and
produces assistant and coat proteins to assemble viruses in a bacterial host. To modify the
genome of MI3 bacteriophage, the replicative form DNA (RF DNAs) is first extracted
from the infected Escherichia coli (E. coli) and digested by specific restriction enzymes.
The designed and synthesized DNA fragment is then recombined with the cleaved RF
DNA. The new recombinant DNA containing the inserted DNA fragment is transfected
into fresh E. coli using electroporation or heat shock to produce more engineered DNAs
and viruses. The whole processing scheme is depicted in Figure 7.
Phage display of random peptides
One important application of phage display is to construct combinatorial peptide
libraries. Synthetic oligonucleotides with fixed length and random codons are fused to
genes II or VIII of MI3 bacteriophage vectors. The fusions are expressed as random
peptides on the surfaces of bacteriophage particles to form library pools. The phage
display peptide libraries is then used for screening peptides to target materials of interest.
Two types of libraries are employed in this thesis. Type 3 libraries are purchased from
New England Biolabs. And, type 8 library is constructed by Dr. Soo-Kwan Lee in Prof.
Angela M. Belcher's lab at M.I.T.
Biopanning
Biopanning is an evolutionary technique employed to select peptides from peptide
libraries in the laboratory (Figure 8). To select a suitable peptide to target a material of
interest, the phage library is exposed to the selected material. Some of the phages bind to
the selected material and some do not. Unbound phages are washed off the material, and
the phages bound to the selected material are eluted from the material surface by
changing the environmental pH or temperature. Those phages eluted from the material
are then sequenced to characterize the peptide motifs on the coat proteins. Meanwhile, the
eluted phages are amplified to serve as the sub-library for the next round of biopanning.
This panning process will be repeated until the consensus peptide motif is found.
II.C. Experimental
II.C.1. Biopanning for anti-gold sequence for pll1 protein under reduced condition
Materials. Phage display libraries Ph.D.-7C7 T" and Ph.D.-12 TM were purchased from
New England Biolabs. All media and solutions were prepared according to the instruction
manuals of the phage libraries. Dithiothreitol (DTT) was purchased from MP
Biochemicals. Gold slides purchased from EMF Corp. were cut into 5 mm x 5 mm
squares.
Biopanning method. 10 ,LL phage library was diluted to I mL with Tris-buffered saline
(TBS). The diluted library solution was added into a microtube containing a gold square.
The tube was rocked for 1 hr at room temperature. After transferring the solution to a
fresh microtube, the library solution was mixed with DTT (1 M. 10 tiL) for 30 min and
then incubated with a fresh gold square for 1 hr. The supernatant was discarded, and the
gold square was washed with 1 mL TBS 10 times. After the washing steps, the gold
square was incubated with Glycine-HCI (pH = 2.2, 0.2 M, 500 utL) for 10 min to elute the
phages physically bound to the gold substrate. The supernatant of glycine-HCI solution
was discarded. The gold square was then incubated with bacteria culture for amplification
(bacterial elution). After 4.5 to 5 hr, the amplified phages were purified and concentrated
to make the sub-library. The sub-library was tittered and the clones in this sub-library
were sequenced. The sub-library was then used to pan for the next round. The procedure
was repeated until a consensus of peptide sequences was found.
Binding affinity test. The selected virus clone from the biopanning was incubated with
DTT (the final concentration was 10 mM) for 30 min. The reduced virus was then
incubated with gold squares for I hr. The same virus without incubating with DTT was
used as the negative control sample in this experiment. The supernatant was discarded
and the gold substrate was washed 10 times with 1 mL TBS buffer. Glycine-HCI solution
was added to elute the bound virus and neutralized to pH 7 with Tris-HCI (pH = 9.2). The
elution was added to the bacteria culture for amplifying the virus, followed by
purification, titration and sequencing. Meanwhile, the gold substrate was incubated in
bacteria culture for bacterial elution and phage amplification, also followed by
purification, titration and sequencing. Both the virus eluted from the Au surface and
remaining on the Au substrate were quantified.
II.C.2. Amplification of type 8+8 and 8+8-3 virus
Materials. Bacteria clone carrying pMoPacl6 vector (phagemid) with anti-gold motif,
LKAHLPPSRLPS (termed p3-Au12), selected by Dr. Daniel Solis, was used as the host.
The helper phage used to induce the amplification in bacterial cells was the wild-type
virus (M13KE, from New England Biolabs) or the virus clones selected in section lI.C.1.
Amplification condition. A hundred-fold dilution of the overnight bacterial culture
harboring the phagemid with anti-gold sequence was prepared in Terrific Broth. The
bacterial culture was grown to mid-log phase (OD 600 - 0.5). 10 LtL helper phage (-10"
pfu/ýtL) was added into the bacterial culture and incubated at 370C for 5 minutes without
shaking. Isopropyl f3-D-thiogalactoside (IPTG, 100 mg/mL) was added to make the final
concentration of 100 ug/mL in the amplification culture. The culture was then incubated
at 370 C for 1 hr without shaking, followed by 5 - 6 hours incubation in the 37'C
incubator shaker. All virus clones were amplified to the concentration of -109 pfu/piL.
SDS-PAGE electrophoresis. The fusion of p3-Aul2 onto the pVIII proteins was verified
and quantified using electrophoresis. Novexi' 16% Tris-Glycine Gels purchased from
Invitrogen were used in electrophoresis. The virus sample was denatured at 950 C for 2
min before loading. Markl2TM (Invitrogen) was used as the protein standard. The
electrophoresis was carried out at 125 V, and the gel was stained using SilverQuestTM
Silver Staining Kit (Invitrogen).
II.C.3. Biopanning for anti-gold sequence using type 8 phage library
Materials. Gold squares (5mm x 5mm) were used for the panning. Type 8 phage library
constructed by Dr. Soo-Kwan Lee was used for the biopanning. In this type 8 phage
display library, peptides containing eight random residues are fused to the major coat
protein. The random octa-peptides are expressed at the N-terminus of pVIII protein where
the first residue of the fusion is preceded by an alanine and the last residue is followed by
the wild-type pVIII sequence. The sequencing primer was -96 gIII sequencing primer
purchased from New England Biolabs. All media and solutions used were the same as
those used for the type 3 libraries.
Panning method. The anti-gold M13 bacteriophage was selected via the screening of a
type 8 phage display library. The type 8 library was exposed to the gold substrate in
Tris-buffered saline (TBS, pH 7.5) containing 0.1% (v/v) Tween-20. After rocking for
one hour, the gold substrate was washed 10 times with TBS (pH 7.5). The bound phage
was eluted by addition of I mL Glycine-HCI (0.2M, pH 2.2) containing lmg/mL bovine
serum albumin (BSA). The eluate was neutralized by adding 300 [tL Tris-HCI (1 M, pH
9.1). A small amount (-10 jgL) of the eluate was plated on LB XGal/IPTG plates. Plaques
on the plates were randomly picked and DNA sequenced. The rest of the eluate was
mixed with Escherichia coli ER2537 (New England Biolabs) host to amplify the
concentration to approximately 109 pfu/uL. This sub-library was used for the next round
of biopanning.
II.C.4. Construction of type 8-3 M 13 bacteriophage
Materials. The replicative form DNA of gold binding virus (p8#9) selected from the type
8 library in Chapter II.C.3. was extracted from the bacterial cells infected by p8#9 clone.
The restriction enzymes Eag I and Acc65 I were purchased from New England Biolabs.
The synthetic oligonucleotide sl and sl-primer were synthesized by Integrated DNA
Technologies. The sequence of oligonucleotide sl was 5'-CATGTTTCGGCCGAACCT
CCACCCTACGATGCTGCAGCAAATGAGAATAAGGATCCCAAGAGTGAGAATA
GAAAGGTACCCGGG-3', and that of the sl-primer was 5'-CATGCCCGGGTACCTTT
CTATTCTC-3'. XL-1 Blue electrocompetent bacteria used for transformation were
purchased from Stratagene.
Genetic modification. The DNA of p8#9 clone was a derivative of M13SK vector, a
modified vector from MI3KE. The MI3SK vector contains Eag I and Acc65 I restriction
sites in gene III. The RF DNA of p8#9 was digested by Eag I and Acc65 I and purified
using electrophoresis. The PCR product of oligonucleotide sl and sl-primer was also
digested by Eag I and Acc65 1. This ds-DNA fragment containing the gene to express the
anti-streptavidin peptide (WDPYSHLLQHPQ, termed p3sl) on pIII protein was then
ligased into the digested ds-DNA of p8#9. The recombinant DNA was electroporated into
XL-1 Blue bacteria for amplification. The produced type 8-3 phage was named #9sl
phage.
MALDI mass spectrum. The peptide display on pVIII proteins was confirmed using
mass spectrometry. 500 tl of the phage-containing supernatant was added with 200 [tL
PEG/NaCl (20% (w/v) polyethylene glycol-8000, 2.5M NaC1) to precipitate phage
particles. The phage pellet was suspended thoroughly with 100 tiL iodide buffer (10 mM
Tris-HCL (pH=8.0), 1 mM EDTA, 4 M Nal) and then added with 250 utL ethanol. After
incubating 10 minutes at room temperature, the sample was centrifuged for 10 minutes to
spin down unwanted DNA. The supernatant was collected for MALDI analysis. The mass
spectrum of the phage proteins in the supernatant was acquired using an applied
biosystem model Voyager DE-STR instrument for matrix assisted laser
desorption/iionization time of flight (MALDI-TOF) mass spectrometry operated at linear
mode.
Enzyme-linked immunosorbent assay (ELISA). The streptavidin-binding motif on pIll
protein was verified using ELISA. Streptavidin-coated 96 plate wells (purchase from
Pierce Biotechnology, Inc.) were blocked with blocking buffer (TBS + 0.05% Tween +
0.1% BSA) for 1 hour and washed with washing buffer (TBS - 0.05% Tween) 3 times.
2-fold serial dilutions of each phage clone were carried out in a row of ELISA plate wells
and incubated for an hour. After washed with washing buffer 3 times, each well was
added with 200 itL horseradish peroxidase (HRP) conjugated anti-M13 antibody (diluted
1:5000 in blocking buffer) solution, incubated for 30 minutes and then washed with
washing buffer 3 times. 200 tl 2', 2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)
diammonium salt (ABTS) solution containing H20 2 (hydrogen peroxide, Sigma-Aldrich)
was added to each well to develop color. HRP turns ABTS substrate from colorless to
green at the presence of H20 2. Green coloration indicated the presence of the MI3
bacteriophage in the well. The intensities of coloration were measured using microplate
reader set at 405 nm.
II.D. Results and Discussion
The genetically controllable functionalities of the M13 bacteriophage make this
virus an interesting templating material. The goal was set to design a virus which could
be anchored onto the gold surface through its piII proteins and mineralized to bind/grow
Au nanoparticles on its pVIIl proteins to form conductive nanowires on the gold substrate.
To reach this goal, the gold-binding affinity and mechanism of the peptide displayed on
pill protein should be distinct from that on pVIII protein. A wild-type pill protein
contains 8 cysteines, forming four disulfide bonds to stabilize the tertiary structure of the
protein. Three of four disulfide bonds are located in the N-terminal domain (Figure 5).10.
1" When treated with reduction agents, the disulfide bond will be reduced to two
sulfhydral (or thiol) groups. Besides, with the presence of reduction agents, the structure
of pill protein will change due to the dissociation of the intra-crosslinkages of disulfide
bonds. The change of protein conformation will change the interaction between pill
protein and the surrounding material.
Additional parameters were therefore introduced in the regular biopanning process
for selecting a distinct peptide motif. The sequences screened from the biopanning for the
anti-gold peptide under reduced condition are shown in Table 1 and 2. The consensus
sequence from Ph.D.-C7CTM library was SHLHSPL, named p3-Au7Clr, and that from
Ph.D.-12 TM library was TMGFTAPRFPHY, named p3-Au12r. Both sequences were rich
in positively charged amino acids such as histadine (H), arginine (R) and lysine (K). In
addition, amino acids containing hydroxyl groups, such as serine (S), threonine (T) and
tyrosine (Y), were also frequently observed. The results of the modified biopanning have
high similarities to that of regular panning performed by others . One of the sequence
screened using regular panning process in the laboratory was LKAHLPPSRLPS, termed
p3-Au 12. This sequence also contains mostly positively charged and hydroxyl groups.
It is well-known that thiol (-SH) group can covalently bind to gold metal. Thus,
introducing cysteines to the N-terminal displayed peptide will also promote the binding
affinity to the gold. To examine the binding affinity of the selected peptide to the gold
could be promoted under the reduced condition, binding affinity tests were carried out.
Experiments showed that p3-Au7Clr clone had the best on-and-off gold-binding
capability. Without treating with the reduction agent, p3-Au7Clr showed no binding
affinity to the gold substrate (Figure 9). In the other words, the gold binding activity was
only triggered in the presence of reduction agent. This peptide would be engineered onto
the M13 bacteriophage to anchor the viral particle on the gold surface through the pIII
protein as discussed in Chapter IV.
The type 8+8-3 virus carrying two distinct anti-gold motifs were engineered using
the phagemid system. This was the virus designed to have two distinct anti-gold binding
mechanisms on pIII and pVIII. A mixed displays of wild-type and p3-Aul2 fusion were
exhibited on pVIII proteins. The helper phage used during the amplification was the virus
containing p3-Au7Clr on the pIII proteins, producing amplified virus with mixed
expressions (wild-type and p3-Aul2) on pVIII and p3-Au7Clr on pill. The SDS-PAGE
protein electrophoresis was used to examine the amount of p3-Au1 2 fused pVlll proteins.
The results showed that the recombinant pVIII proteins displayed on the virus were less
than 5% overall (Figure 10). This estimation was based on the comparison of band
intensities between the wild-type pVIII band and the p3-Aul2 fused pVIll band. The
expression ratio of the fused pVIII proteins was about 27-fold lower than that of
wild-type proteins. For a M13 bacteriophage containing 2700 copies of pVlll protein,
there were about 100 copies of fused p3-Aul2 pVIII protein. This low expression ratio
resulted in deficient gold mineralization performed on this engineered virus. The details
of the gold mineralization on virus templates to make Au nanowires are discussed in
Chapter III. The low expression ratio might result from the low yield of recombinant
pVIII proteins produced from the phagemid vector or other unknown viral assembly
factors.
Although the type 3 library is the most commonly used screening pool, which is
based on a combinatorial library of random peptides fused to pIII proteins, peptide motifs
screened from a type 3 library cannot be directly translated to pVIII proteins because pIII
and pVIII proteins have their distinct structure information. Fusing binding motifs chosen
from the type 3 phage library to pVIII proteins may cause a deviation in the functionality
of the displayed motifs and vice versa.1 Therefore, to identify the desirable peptide
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motifs for pVIlI proteins in addition to avoiding the problem of low expression ratio
mentioned above, a type 8 engineered library was exploited. It was used for the first time
to select the gold-binding peptide for pVIII proteins.
The type 8 library was constructed by fusing eight random amino acids into the
N-terminus of all the 2700 copies of the pVIII proteins"s with a random population of
10 -108 . This library employed a modified M13KE phage vector (referred as the
wild-type in the following chapter) by generating restriction sites, PstI and BamHI, in
gene VIII through mutagenesis for the insertion of random codons (Gnm(nnm)6nnG),
where n = G, C, A or T and m = T or G. Unlike the previously described phage
engineered using a phagemid system, phage in the type 8 library employ genome
engineering that produces 100% expression and monodispersed viral dimensions.,
Through the use of a general biopanning technique by exposing the type 8 phage library
to gold thin films, anti-gold binding motifs on pVlllI proteins were selected. The peptide
sequence VSGSSPDS, which is named p8#9, emerged as the dominant binding motif
after the forth round of the selection. The sequences screened from the panning process
are listed in Table 3. This gold-binding motif contains four serines, each of which has a
hydroxyl group on the side chain (Figure 11). Hydroxyl-rich peptides have been reported
to have high affinity to gold lattices.1 5" " Other data obtained from the biopanning of the
type 3 library also show that hydroxyl-rich motifs are favorable for binding gold surfaces.
Similar to the results that were obtained from the type 3 phage display libraries, the
consensus peptide motif evolved from the biopanning of type 3 library was also rich in
hydroxyl groups. Unlike the previous engineering scheme to transform the peptide
selected from pIII protein to pVIII protein, the peptide selected from type 8 library is
directly to be used on p•lII.
To extend the applications of this type 8 phage, p8#9, another peptide motif can be
integrated into its pillI proteins. The pill protein was genetically engineered with
anti-streptavidin motif.'9 This new type 8-3 phage was hence named #9sl clone (Figure
12). The anti-streptavidin motif displayed in plll protein, which is named p3sl, can bind
streptavidin independently with the existence of peptide p8#9 in pVIII proteins in the
same phage particle. The functionality of the p3sl binding motif was verified by an
enzyme-linked immunosorbent assay (ELISA)-based method (Figure 13). Each well of
the ELISA plate was coated with streptavidin that can be bound by p3sl motif. Green
coloration indicated positive interaction, and the intensity of the green color represents
the amount of the bound phage in the well. The result showed that both #9sl and p3sl
had predominant binding affinities to streptavidins. It also proved the successful
expression of sl motif on pIII proteins in clone #9sl. Furthermore, the expression of the
p8#9 motif on pVIll proteins was proven by mass spectroscopy. The peak at 5655.25 Da
in the mass spectrum of #9sl corresponded to the molecular weight of the engineered
pVIll proteins, indicating that the anti-gold motif (p8#9) was 100% displayed on the
pVIII proteins of bacteriophage (Figure 14). Another peptide motif, p3-Au7Clr was
integrated into this p8#9 clone to create another type 8-3 clone, named #9-Au7Clr. This
virus was used for grafting gold nanowires onto a gold substrate for biosensor in the
Chapter IV.
II.E. Conclusion
Biopanning has greatly accelerated the design of peptide or protein for various
applications. However, the success of a biopanning relies on the choice of library. It is
extremely essential to have various types of libraries to fit the needs of peptide designing
and engineering. Using the peptides selected from libraries also can avoid the problems
of compatibility issues and mutations occurring in the transformations of rationally
designed peptides. In addition, mutagenesis studies assisted with biopanning can be
carried out to reveal the importance of individual amino acid in selected peptides for
specific binding affinity/mechanism.
M 13 bacteriophage is an ideal template that can be easily manipulated and modified
to accommodate the needs of engineering. Engineering viral template can be
accomplished and precisely controlled at molecular and nanometric scale. Several types
of engineering on the M13 virus were demonstrated and proved in this chapter. In the
following chapters, the applications of this viral template will be used to make materials
for electronics, sensors, and fibers.
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Table 1. Biopanning of Ph.D.-7C7T library for gold binding sequence under
reduced condition. Positively charged amino acids, histidine (H), lysine (K), and arginie
(R), and hydroxyl amino acids, serine (S), threonine (T), and tyrosine (Y) frequently
observed in the peptides screened from the library. Successive positively charged and
hydroxyl amino acids were mostly present in these peptides.
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Table 2. Biopanning of Ph.D.-12 TM library for gold binding sequence under reduced
condition. Positively charged amino acids preceding or following hydroxyl amino acids
were observed in the peptides screened from the library. However, no specific peptide
motif predominated in the biopanning.
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Table 3. Biopanning of type 8 library for gold binding sequence. In the first round,
wild-type virus was dominant. A sequence, named p8#9, started dominating in the second
and rest of rounds. The sequences observed in this biopanning also contained hydroxyl
amino acids as observed in the biopannings using type 3 libraries shown in Table 1 and 2.
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Figure 1. Commercialized M13 bacteriophage vector M13KE. It was designed for the
convenience to insert an engineered peptide into pIII protein through Acc65 I and Eag I
restriction sites. M13KE vector was used to construct the new vector M13SK for type 8
library and other types of engineered viruses. (Source: New England Biolabs catalog)
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Figure 2. Schematic representation of M13 bacteriophage and summary of coat
proteins. M13 bacteriophage is a filamentous virus with 880 nm in length and 6 - 7 nm in
diameter. It has five types of coat protiens encasing the viral DNA. pVIII protein is the
major coat protein, which has 2,700 copies per bacteriophage. Other proteins are the
minor coat proteins.
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Figure 3. Molecular models of pVIII proteins packed on M13 bacteriophage. Side
view (left) and cross section (right) of the assembled pVIII proteins. The molecular
surfaces were colored by (a) individual pVIII proteins, (b) accessibilities to the
surrounding environment, (c) types of amino acids. In figure (c), negatively charged
amino acids (red) are mostly present on the outer surface, and positively charged amino
acids (blue) are densely located in the core of virus capsid to stabilize the viral DNA,
which is negatively charged. Hydrophilic amino acids (yellow) are present both in the
outer and inner regions of coat proteins. (Software: Swiss-PDB; Structure Model: IIFJ)
Figure 4. Molecular model of single pVIII protein. (Left) The ribbon structure colored
by the types of amino acids shows alpha helical structure of pVIII protein. (Right) The
molecular surface colored by the types of amino acids shows that negatively charged
amino acids and hydrophilic amino acids are mostly present in the N-terminal region.
Hydrophobic amino acids for adhering neighboring pVIII proteins are present in the
middle to C-terminal region of pVIII protein. Positively charged amino acids are located
at the C-terminal region. (Software: Swiss-PDB; Structure Model: IFJ)
Figure 5. Molecular model of the N-terminal domain of pIII protein in ribbon
structure. pIII protein is a globular protein containing alpha- and beta-structures. In the
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N-terminal domain, there are three disulfide bonds (in blue) comprised of six cysteines to
hold the tertiary structure of pIII protein. The peptide insert is commonly displayed in the
coil region following the alpha helix at N-terminus shown on the right of the picture.
(Software: Swiss-PDB; Structure Model: IG3P)
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Figure 6. Various types of genetic modifications. Four types of engineering schemes
are illustrated. Type 3 virus contains engineered peptides on pill proteins, and type 8 has
modified pVIII proteins. Type 8-3 contains two distinct peptide motifs on pIll and pVHII
proteins engineered through the viral genome. Type 8-8-3 is a derivate of type 8-3 virus.
It contains two peptide motifs displayed in pVII1 proteins. One is originated from the
phagemid, and the other one is from the viral vector.
00
O
ds-DNA replicated in E. Coli
0ooo
Ligation
O DNA Fragment
Electroporation
Recombinant DNA
Amplification
Figure 7. Recombination and transformation. A flow chart of genetic engineering
procedure. The virus containing a single-stranded DNA (ss-DNA) infects an E. Coli host
and produces double-stranded DNAs (ds-DNAs) in the bacterial cell. The ds-DNA
(replicative form DNA) is extracted and digested with restriction enzymes. Synthesized
DNA fragment is ligased into the digested ds-DNA. And, the recombinant DNA is
electroporated into a fresh E. Coli to produce engineered M 13 bacteriophages.
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Figure 8. Procedure of biopanning. Phage library containing about millions of random
sequences is exposed to the material of interest. After washing unbound phages, the
bound phages are eluted from the surface and sequenced to analyze the peptides. The
eluate is amplified and then used for the next round of biopanning. The panning steps are
repeated until a consensus sequence is found.
Figure 9. Titration of virus p3-Au7Clr bound to gold surface. Two samples were
prepared: one was treated with DTT, and the control was treated without DTT. Plates on
the left hand side were tittered from the sample treated with reduction agents (DTT)
before binding, and the plates on the right hand side were tittered from the other sample
treated without reduction agents. The virus showed no affinity to gold surface if it was
not treated with DTT. The binding affinity to gold would increase when the virus was
treated with DTT.
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Figure 10. SDS-PAGE electrophoresis for analyzing displayed pVIII protiens. Lane
1 was the DNA standard (Markl2TM). Lane 2 was p3-Au7Clr virus. Lanes 3 to 9 were
the 3-fold serial dilutions of type 8+8-3 virus amplified using phagemid system. The band
of recombinant pVIII protein (p3-Au12, circled in red) in lane 5 showed approximately
the same intensity of the wild-type pVIII protein in lane 8, indicating that the estimated
expression ratio of fused pVIII proteins was approximately 33=27-fold lower than that of
wild-type pVIII proteins. Given the pVIII protein of about 2,700 copies for M13
bacteriophage, the number of fused pVIII proteins was approximately 100 copies per
bacteriophage.
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gVIII 5'- GCT GAG GGT GAC GAT CCC GCA AAA GCG GCC TTT AAC TCC CTG CAA GCC TCA GCG.... -3'
pVIII N- Ala Glu Gly Asp Asp Pro Ala Lys Ala Ala Phe Asn Ser Lys Gin Ala Ser Ala .... -C
p8#9
gVIII 5'- GCA GTG TCG GGG TCG TCG CCG GAT TCG GAT CCC GC/AA GCG GCC TTT -C TCC .... -3'
pVIII N- Ala Val Ser Gly Ser Ser Pro Asp Ser Asp Pro Ala Lys Ala Ala Phe Asn Ser .... -C
Figure 11. The comparison of wild-type (M13KE) and p8#9. (a) Schematic
representations of wild type and type 8 engineered bacteriophages. Type 8 engineered
bacteriophage bears an insertion in gVIII genome, which leads to a displayed
octa-peptide motif (shown in orange color) on each major coat protein. (b) The
comparison of gVIII sequences and corresponding peptide sequences between a wild type
phage and a p8#9 phage. The differences are highlighted in grey. Type 8 gold-binding
virus p8#9 contains octa-peptide, which replaces the tri-peptide in the wild-type pVIII
proteins of M13KE virus.
#9s1
modified gVII and gill displayed peptides
gVill 5'- GCA GTG TCG GGG TCG TCG CCG GAT TCG GAT CCC GCA AAA GCG GCC TTT AAC TCC .... -3'
pVll N- Ala Val Ser Gly Ser Ser Pro Asp Ser Asp Pro Ala Lys Ala Ala Phe Asn Ser .... -C
gill 5'- TGG GAT CCT TAT TCT CAT TTG CTG CAG CAT CCG TAG GGT GGA GGT TCG GCC GAA .... -3'
pill N- Trp Asp Pro Tyr Ser His Leu Leu Gin His Pro Gin Gly Gly Gly Ser Ala Glu .... -C
Figure 12. Engineered type 8-3 virus. (Top) Schematic representation of the type 8-3
engineered phage, #9sl. It contains gold-binding motifs (p8#9) fused on pVlII proteins
-j1~55~4
and anti-streptavidin motifs (p3 sl) fused on pIII proteins. (Bottom) The DNA sequences
of gVIII and gIII and the corresponding pVIII and pIII coat proteins 
are listed. The
engineered genome and peptide in the virus are highlighted in gray. p8#9 
motif contains
eight amino acids and p3sl motif contains 12 amino acids.
Figure 13. Enzyme-linked immunosorbent assay (ELISA) to verify the expression of
anti-streptavidin peptide. ELISA plate result of the interactions between 
the sl motif
and the streptavidin-coated wells. The green color indicates positive interaction. 
The
intensity of the green color represents the amount of the bound phage in the 
well. Serial
dilutions (50%, 2-fold) of each phage clone were carried out in a row of ELISA plate
wells.
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Figure 14. The mass spectra of wild-type (M13KE) and #9sl clones. Experimental
proofs confirmed the wild-type pVIII protein on M13KE clone and the display of p8#9
gold-binding motif on #9s 1 clone.
Chapter III. Biological assembly of nano-materials and
nano-structures
III.A. Summary
Biological systems possess inherent molecular recognition and self-assembly
capability and are attractive templates for constructing complex material structures with
molecular precision. The assembly of various nanoachitectures including nanoparticle
arrays, hetero-nanoparticle architectures and nanowires utilizing highly engineered M13
bacteriophage as templates are reported.'" '3 The genome of M13 phage can be rationally
engineered to produce viral particles with distinct substrate-specific peptides expressed
on the filamentous capsid and the ends, providing a generic template for programmable
assembly of complex nanostructures. Phage clones with gold binding motifs on the capsid
and streptavidin-binding motifs at one end were created and used to assemble Au and
CdSe nanocrytals into ordered one-dimensional arrays and more complex geometries.
Initial studies showed such nanoparticle arrays could further function as templates to
nucleate highly conductive nanowires providing a new avenue for
addressing/interconnecting individual nanostructures." - In this chapter, type 8-3
engineered phage is demonstrated to serve as templates to assemble nanoarchitectures of
various geometries and materials, such as Au and CdSe nanocrystal/hetero-nanocrystal
arrays and Au nanowires.
III.B. Introduction
Biological molecules for nano-templating
One of the important issues in the future nano-world is the structural control of
materials at the nano-scale. This has attracted a lot of attention to the fabrication of
different architectures with various dimensions, ranging from zero-dimensional
nanoparticles to three-dimensional nanonetworks." ~7 To efficiently build complex
nanostructures in the future, more knowledge and well-developed techniques are required
to control the building blocks at the molecular level. And, these so-called building blocks
usually have low dimensional structures. In the last decade, many approaches have been
reported to fabricate one-dimensional metallic, semiconducting and magnetic nanowires.
These approaches include, but not limit to, vapor-liquid-solid reaction",
electrochemical deposition" ••, photochemical reduction ", surfactant-directed" and
template-directed'" syntheses. Although these techniques may produce good quality
nanowires, few of them can make nanowires of controlled and monodispersed lengths.
Recent efforts focused on the bottom-up assembly of functional nanosystems from
nanoscale building blocks have led to substantial advances. However, the
difficulties in precise placing and interconnecting individual building blocks --642 have
impeded further progress and thereby motivated significant efforts directed towards
controlled assembly of nanoscale building blocks.43- a Biosystem is one of them.
Biological systems are highly organized from molecular-scale building blocks such as
nucleic acids and proteins with intricate hierarchical architecture and represent the
unparalleled examples of bottom-up assembly.46" Biological molecules often possess
highly specific and precise molecular recognition capability that can be programmed
through genetic engineering48 -5 and can exert rational control over inorganic material
nucleation, phase stabilization, assembly and pattern formation at molecular scale.5,-5
Integration of these unique capabilities of biomolecules with the design of new materials
can offer many opportunities for nanofabrication including rational molecular design
through genetics, spatial control on nanometer scale, and hierarchical assembly of
two-dimensional (2D) or three-dimensional (3D) complex architectures."•'
Biological templates for nanowires
Biological templates for fabricating nanomaterials have drawn a lot of attention due
to the self-assembly and low-temperature synthesis process. To date, biological templates
can be categorized into three main types: deoxyribonucleic acid (DNA), peptide and
protein, and filamentous virus. The fabrication ofnanowire using the biotemplate is based
on either "buttom-up" 55, 61-63 or "top-down" 64-66 concept (Figure 1). In "bottom-up"
method, the structural unit of the DNA or peptide is first modified to create a ligand to
bind a precursor or attached with a preformed nanoparticle. Next, the modified structural
unit is elongated in one dimension to form a wire-like structure. Finally, the wire-like
biomaterial is used as the template to grow a material on it. As for the "top-down"
method, amphiphilic peptides are used to make a micro- to nano-tubular structure, and
then the material is nucleated inside the tube. After the nanowire forms inside the tube,
the peptide scaffold is removed by dissolving them in a solvent or by heating it up. As for
the filamentous virus being used as a template, both "bottom-up" and "top-down"
methods have been reported.
However, in either of the biotemplating schemes. there are two important issues.
One is to effectively modify the building block for templating a material, and the other is
to control the dimensions of the template when propagating the building block. Each
bio-template has its own advantages and disadvantages. Of these biological templates, the
lengths of both DNA and filamentous virus can be genetically controlled, and
peptide/protein is more stable than DNA. DNA only has four types of building blocks -
nucleotides; and protein has twenty types of building blocks - amino acids. Although the
diversity of protein is much more than that of DNA, the synthesis and construction of
protein material are difficult. Fortunately, nature has developed controllable protein
templates - viruses. Virus is a genetic product of the viral DNA, which assembles and
fabricates virus progeny in its host. The coat proteins (or capsid) of a virus protect the
viral genome and function to infect and transport viral DNA into the host. Viruses can be
seen as the nature products combining all the advantages of the protein and DNA
templates. Moreover, filamentous virus such as M13 bacteriophage has a high aspect
ratio structure. This inherent property also makes the filamentous virus an interesting
template for making nanowires.
III.C. Experimental
III.C.1. Self-assembly of nanoparticle array
Materials. To demonstrate the specific templating effect of p8#9 motif, experiments
were carried out with different clones, including p8#9 (positive motif), negative control
wild type and p8#17 (a random motif selected from type 8 library). Each virus solution
was amplified, purified, and diluted in water to 109 pfu/pL. 5-nm gold colloidal
suspension (5.0 x 1013 particles/mL, Ted Pella), streptavidin-coated 15-nm gold
nanoparticle (Ted Pella), streptavidin-conjugated cadmium selenide (CdSe) quantum dots
(Quantum Dot Corp.), and bovine serum albumin (BSA, Amersham Biosciences) were
prepared.
Binding test. 10 p1 of the phage solution was mixed with 100 Cl of 5-nm gold colloidal
suspension (without dilution). The mixture was incubated on ice for I hr.
Synthesis of hetro-particle nanoarray. #9sl clone was first amplified to -109 pfu/p~L.
10Ll of the phage solution was mixed with 5[l of 15-nm Au-streptavidin conjugates (or
streptavidin-conjugated CdSe quantum dots) and 70 [tL of TBST (tri-buffer saline (TBS)
+ 0.05[v/v] Tween-20 + 0.1% mL bovine serum albumin), and the mixture was agitated
for about I hour, allowing sl on the pII proteins to bind to streptavidin-coated gold (or
streptavidin-conjugated CdSe quantum dots). Then, 10 gtL of the mixture solution was
incubated with 100I L 5-nm colloidal Au to allow the second type of nanoparticle to bind
to pVIII proteins.
III.C.2. Synthesis of gold nanowire using direct nucleation and electroless deposition
Materials. p8#9 clone was first amplified, purified and diluted to -109 pfu/jtL. HAuCI4
(chloroauric acid), NaBH4 (sodium borohydride) and NH 20H (hydroxyl amine) was
purchased from Sigma-Aldrich. 5-nm gold colloidal suspension was purchased from Ted
Pella.
Direct nucleation for nanowire. To synthesize gold nanowires by the reduction reaction
from gold salt, 10 gtL of the virus was first mixed with 100 gL chloroauric acid solution
(HCI4Au, 5 mM, pH = 5.5) at 0 'C. The gold precursor was reduced by the addition of
iced-cold sodium borohydride solution (50 ptl, 5 mM). The reaction was incubated on ice
for 3 hours.
Electroless deposition for nanowire. This was achieved by electroless deposition of
gold onto the existing Au nanoparticle arrays using the catalytic effect of gold surface to
selectively reduce gold from HAuCl 4 solution at the presence of NH 2OH. 80 iL HAuC14
(0.3 mM) was added with 10 4tL nanoparticle array obtained previously, and the mixture
was then mixed with NH2OH (40 mM) and incubated on ice.
III.C.3. Sample preparation for microscopy and electronic characterization
Materials. Silicon wafers with and without oxide layer (-100 nm) were purchased from
University Wafer. TEM copper grids with carbon films were purchased from LADD
Research. Uranyl acetate was purchased from EMS Corp.
Microscopy. 10 to 100 4L of sample was dispersed on the silicon wafer and incubated
for 30 min. The sample was removed by filter paper and the wafer was briefly rinsed with
water. Atomic force microscopy (AFM) images was taken by VEECO MultiMode V
(Digital Instruments) operated under tapping mode to verify the connection of viral
nanowires and electrodes. The TEM images were taken using JOEL 2010 high resolution
transmission electron microscope (HR-TEM) operated at 200 kV. Uranyal acetate stained
samples were prepared by floating on 50 L.L uranyl acetate solution (-2%).
Electronic characterization. To measure the electrical properties of these nanowires,
samples were dispersed on silicon substrates with oxide layers (SiO2) containing large
electrode patterns and further connected to the electrodes by focused ion beam (FIB)
metal deposition or electron beam (EB) patterning. The current transported through the
virus-based nanowire was measured by sweeping the voltage at room temperature using a
probe station.
III.D. Results and Discussion
The viral capsid with expressed anti-Au motifs selected in Chapter II on pVIll
proteins served as a template for organization of one dimensional (1 D) Au nanocrystal
array. To demonstrate the specific templating effect of p8#9 motifs, experiments were
carried out with different clones, including p8#9(positive motif), negative controls wild
type and p8#17 (a random motif selected from Type 8 library). After 2-3 minutes of
incubation, the mixtures of control clones with the gold colloidal suspension and the
blank control gold suspension remained clear (Figure 2). Transmission electron
microscopy (TEM) studies on these samples showed that gold particles distributed
randomly in the control sample (Figure 3a). Uranyl acetate stained samples showed
clearly that Au nanoparticles were not templated by either wild type phage or p8 #17
clones (Figure 3b and c). In the case of motif p8#9, a visible precipitate in the solution
was observed, indicating that gold colloids formed aggregates. TEM studies showed that
gold nanoparticles assembled into wire-like structures with diameters around 10 nm and
lengths around 1 gm, which are consistent with the morphology of M13 virus (Figure
3d). Enlarged image revealed that gold nanoparticles were arranged into ordered I D array
on pVIII proteins along the viral axis (Figure 3 insert). One-dimensional metallic
nanoparticle arrays may serve as the basis for plasmon structures that can selectively
absorb or transmit specific electromagnetic radiation with high spectral sensitivity. 67
With the successful modifications on both pIII and pVIII proteins, type 8-3 phage
can serve as a template for assembly of nano-architectures with rich geometries and
functionalities. #9sl clones can further be utilized to assemble hetero-structures with gold
particles forming 1D array on pVIII proteins and another streptavidin-coated material
bound to pill proteins. #9s1 clone was first mixed with 15-nm Au-streptavidin
conjugates, allowing st on the pIII proteins to bind to streptavidin-coated gold. Then, the
mixture solution was incubated with 5-nm colloidal Au to allow gold nanoparticles to
bind to pVlll proteins. Resulting structures were examined with TEM. The images
revealed that 5-nm gold particles formed a ID array on pVII proteins and the
streptavidin-coated 15-nm gold particles bound to one end of the phage as the result of
functionalities on pIII proteins (Figure 4a and b). This rational approach provides the
assembly of nanostructures based on genetic engineering of the viral system and can
easily be extended to other materials/structures. For example, when streptavidin-coated
Au was replaced with streptavidin-conjugated cadmium selenide (CdSe) quantum dots,
hetero-nanoparticle arrays consisting of CdSe quantum dots (QD) bound to pIII proteins
and gold nanoparticles arrays bound to pVIII proteins were obtained (Figure 4c). More
than one phage could connect to the same streptavidin-coated nanoparticle and created
more complex structures, such as a linear wire-dot-wire construct or a Y-shape structure
(Figure 4d and e).
Moreover, the ID metallic nanoparticle arrays on pVll proteins could subsequently
grow into continuous metallic nanowires. This was achieved by electroless deposition of
gold onto the existing Au nanoparticle arrays using the catalytic effect of gold surface to
selectively reduce gold from HAuCl4 solution at the presence of NH2OH.68 The growth of
the ID nanoparticle arrays into continuous nanowires was verified by TEM studies,
which revealed a progressive growth of the nanowires with increasing electroless
deposition time. By controlling the electroless deposition time continuous Au nanowires
can be achieved (Figure 5). Continuous nanowires obtained after 5 minutes of deposition
have an average diameter of - 40 nm.
Gold nanowires was also obtained from direct nucleation from gold salt solution
onto the pVIII proteins of the viruses. To synthesize gold nanowires by the reduction
reaction from gold salt, virus sample (- 109 pfut/pl) was first mixed with chloroauric acid
solution and incubated on ice. The gold precursor was reduced by the addition of
iced-cold sodium borohydride solution. The whole reaction was carried out on ice. All the
samples showed visible precipitates after 1-hr incubation (Figure 6). TEM studies on
these samples showed that the control sample without adding any virus only contained
100 nm gold nanoparticles (Figure 7a). The samples with negative control virus clones,
wild-type and p8#17, showed mixtures of 100-nm and other smaller gold nanoparticles
(Figure 7b and c). No nanowire was observed in these control samples. In the sample
with p8#9, a large quantity of virus-based gold nanowires with uniform length was
observed (Figure 7d). The gold nanowire was approximately 20 to 30 nm in width and
900 nm in length. The electron diffraction (ED) pattern of an individual nanowire showed
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a combination of ring and spot patterns (Figure 8). This indicates that the nanowires were
comprised of many single crystalline regions with random orientations on pVIII proteins.
The scattering spots shown in the electron diffraction pattern correspond to various gold
crystalline facets (111), (200), (220), (311), (222), (331) and others, which confirmed that
the material synthesized on the bacteriophage surface was pure gold. Further analysis of
ED patterns at individual segments did not show any specific alignment of the gold
crystals along the viral nanowire (Figure 8).
To probe the mechanism of crystal growth on bacteriophage, ultraviolet-visible
(UV-Vis) spectroscopy was used to monitor the formation of gold nanowires. Within ten
minutes after the addition of the reduction agent, the UV-Vis spectrum showed a main
transverse plasmon absorption peak of the gold nanoparticles at 521 nm (Figure 9). At
this stage, segregated gold nanoparticles were formed on the bacteriopahge major coats
and in the solution. After 3-hr reaction, the aggregation of gold particles was observed
and the UV-Vis spectrum showed the characteristic curve of aggregated gold
nanoparticles at the high wavelength range. On the other hand, the gold nanoparticles
produced from the same reduction method and condition exhibited a transverse plasmon
absorption peak around 521 nm, corresponding to 15-nm Au nanoparticle. From the high
resolution TEM lattice images (Figure 9), some regions of the nanowire were comprised
of 15-nm nanoparticles with well-defined particle shapes. This indicated that pVlll
proteins also bound the gold nanoparticles that nucleating in the solution. The other parts
of the nanowire did not have distinguishable 15-nm nanoparticles, indicating the
coalescence and growth of gold randomly occurred on the pVlll proteins. These portions
were mostly composed of polycrystals owing to the asymmetric growth and multiple
nuclei forming within these regions. The gold nanoparticles were initially formed both on
pVIII proteins and in solution during this synthesis. Both nucleation and physical
adsorption were simultaneously occurred in the peptide-directed bio-mineralization
process. Comparing the coverage of gold nanoparticles on type 8 virus with that on type
8+8 virus (engineered using phagemid system), type 8 virus showed better coverage due
to the gold-binding motifs were fused on all pVIII proteins. As proved in Chapter II, the
recombinant pVIII proteins on a type 8+8 virus were only about 4%, resulting incomplete
coverage of gold nanoparticles on the virus template (Figure 10).
To further investigate the potential of these biotemplated nanowires as electronic
components in future nanoelectronic circuitry, electrical transport studies were performed
on individual nanowires. Electron-beam (E-beam) lithography and focus ion beam (FIB)
deposition were used to make electrical contacts to the nanowires, and the contacts were
verified using AFM (Figure 11 and Figure 12). Two-terminal current-voltage (I-V)
measurements were conducted at room temperature. For a continuous nanowire, the
current-voltage curve showed a linear relation, indicating the ohmic contact behavior.
Repeated measurements on the nanowire yielded reproducible I-V behaviors, indicating
that the device was stable. A resistance of about 588 ohm is estimated for the device.
These data give a resistivity - 1.8 X 10- 6-m for the gold nanowire, which is about 100
times larger than the bulk gold (2.24X10 -8 I -m). Diameter fluctuation, surface scattering
and tunneling through different nanocrystal grain boundaries may contribute to this
result. With increasing bias voltage the device failed when the current reached around
500 [tA, which yielded a high failure current density about 10, A/cm 2.
III.E. Conclusion
Type 8-3 engineered phage was demonstrated to serve as the template to assemble
nanoarchitectures of various geometries and materials, including Au and CdSe
nanocrystal/hetero-nanocrystal arrays and Au nanowires. These results suggest a generic
assembly approach that can be extended to program the assembly of various material
systems with nanometric precision: various substrate-specific motifs can be
independently selected from type 8 and type 3 libraries and then genetically incorporated
into M13 bacteriophage structures to produce highly decorative viral templates with
rational controls (Figure 13). The type and amount of peptide motif displayed on pVIII
proteins will directly affect the nucleation and binding result. The experimental results
showed that using 100% peptide display on pVIII protein, which was the type 8 virus,
gave the best coverage of particles to produce nanowires. Overall, this chapter
demonstrates the great promise of bottom-up assembly for sophisticated electronic and
optoelectronic systems from biotemplated materials and therefore opens up many
exciting opportunities in nanoscale science and biotechnology.
III.F. Figures
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Figure 1. Self-assembly of biological templates. (a) Bottom-up: the construct unit is
modified and polymerized into a long linear chain. Material is directly growing on the
template. (b Top-down: amphiphilic molecules such as lipid or peptide are self-assembled
into a hallowed scaffold, and an inorganic material is filled in and shaped by the scaffold.
The biological template can be removed by heating or dissolved by solvents.
Figure 2. Gold-binding experiments. The photograph of different clones mixed with Au
nanoparticles. Only sample p8#9 showed visible precipitate, highlighted by the arrow. All
the other solutions remained clear.
Extension
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Figure 3. Corresponding TEM images of gold-binding experiments. (a) Au
nanoparticles (blank control sample). (b) Wild-type phage mixed with Au nanoparticles
(negative control sample), stained with 2% uranyl acetate. (c) Sample p8#17 mixed with
Au nanoparticles (negative control sample), stained with 2% uranyl acetate. (d)
Distinguishable wirelike structures in the mixture of sample p8#9 and Au particles. The
inset shows Au particles self-assembled into 1D arrays on the virus.
Figure 4. TEM images of various nanoarchitectures templated by clone #9sl. Gold
nanoparticles (- 5 nm) bind to pVIII proteins along the virus axis and form ID arrays,
while sl motif on pIII protein simultaneously binds to streptavidin-coated nanoparticles.
Arrows highlight the streptavidin-conjugated gold nanoparticles (- 15 nm) and CdSe
quantum dots bound on pIII proteins. The insets show the assembly schemes of observed
structures. White represents the virus structure, yellow dots represent gold nanoparticles,
the green dot represents a CdSe quantum dot, and red represents the streptavidin coating
around gold or CdSe particles. (c, inset) The enlarged image of the CdSe quantum dot
attached to the end of the virus.
+Au3 + NH2OH --
Figure 5. TEM images of the progressive growth of continuous gold nanowires
templated by gold nanoparticle arrays on pVIII proteins. The growth of continuous
gold nanowire (a) before electroless deposition, (b) 3-min deposition, and (c) 5-min
deposition. (d) A full image of a gold nanowire. (Bottom) The reaction of electroless
deposition of gold. The reduced gold metal is preferentially deposited onto the preformed
gold particle.
Figure 6. Gold nucleation experiments. The photograph of different
chloroauric acid solutions (HC14Au) after adding sodium borohydride
agent). All the samples showed visible precipitates.
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Figure 7. Corresponding TEM images of gold nucleation experiments. (a) Gold salt
solution (5 mM chloroauric acid + 5 mM sodium borohydride). (blank control sample). (b)
Wild type phage mixed with Au salt solution (negative control sample). Stained with 2%
uranyl acetate. (c) Sample p8#17 mixed with Au salt solution (negative control sample).
Stained with 2% uranyl acetate. (d) Distinguishable wire-like structures in the mixture of
sample p8#9 and Au salt solution.
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Figure 8. Electron diffraction (ED) patterns and TEM images of gold nucleation
nanowires. (Left) Diffraction patterns of individual gold nanowires. The scattering spots
corresponded to different gold crystalline facets. (Right) TEM images of viral gold
nanowires. (Right insets) ED patterns of different regions on individual nanowires.
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Figure 9. Ultraviolet-visible spectrum (UV-vis) and TEM image of gold
nanopartilces nucleating on the virus. (Left) A transverse plasmon absorption peak
corresponding to 15-nm gold nanoparticles was observed at 521 nm.Viral gold nanowire
showed characteristic longitudinal plasmon absorption at the high wavelength range.
(Right) TEM image confirmed discrete 15-nm gold nanoparticles bound to the virus,
which was the proof of binding mechanism concurring with nucleation growth on the
virus template.
Figure 10. Type 8+8 gold-binding virus template. The virus template engineered using
the phagemid system showed incomplete coverage of gold nanoparticles. The estimated
amount of recombinant pVIII proteins for one M13 bacteriopahge was 4% (See Chapter
II).
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Figure 11. Atomic force microscopy (AFM) image and electrical property of
electroless deposited gold nanowire. (Left) Three-dimensional plot of an AFM image of
a two-terminal device based on a single viral gold nanowire fabricated using electroless
deposition. (Right) The two-terminal current-voltage (I-V) behavior of a nanowire
measured at room temperature.
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Figure 12. Scanning electron microscopy (SEM) images and electrical property of
gold nucleation nanowire. (Left) SEM images of connected nanowires before and after
depositing platinum contacts using focus ion beam (FIB). (Right) The I-V behavior of a
virus-based gold nanowire showed linear relation and ohmic contact.
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Figure 13. Scheme of engineering type 8-3 virus for templating various
nano-sturctures. The binding motifs are selected from different types of libraries and
fused into one virus. This multiple-engineered viral template can be used to create several
types of nano-architectures.
Chapter IV. Virus-based biological sensor
IV.A. Summary
M13 bacteriophage is a genetically controllable toolkit for material designs to
templating inorganic materials such metals and semiconducting materials. However,
there is no research that reports to engineer bacteriophage for integrating enzyme with
inorganic materials to construct useful devices. Phage display for fabricating devices such
as enzymatic electrodes provides several advantages: 1) the orientation of the enzyme
attaching to the electrode can be controlled; 2) the electron communication pathway can
be precisely constructed; 3) hetero-functionalities to conjugate enzyme and nanomaterials
can be easily altered through standard genetic modifications. The biological assembly
process can ensure the alignment of expressed enzyme on the template and avoid the
issues of inefficient random orientation of active molecule. The MI3 bacteriophage
template provides various engineering routes to tailor the electron communication
channels because of the diverse functional groups and proteins presenting on the surface
of the template. And, the most important feature is that M13 bacteriophage provides
flexibilities and capabilities to be engineered and tuned easily by modifying the genome.
In this chapter, the possibility of displaying and chemically conjugating enzyme on the
filamentous bacteriophage that also can incorporate metals will be discussed.
IV. B. Introduction
Virus-based devices
Applications of biomolecules such as protein and DNA in devices have drawn a
lot of attentions. One of the reasons is the precise displacement of materials and
construction of rich structures that these biological templates can control at the nanometer
scale. Other reasons are the ambient assembly/fabrication processes that are compatible
to the integration of environmentally sensitive materials/molecules, such as enzymes. The
last reason is that the virus template has more flexible engineering capabilities than
DNAs or other protein molecules. Both functionalities and structures of virus such as
M I3 bacteriophage can be precisely controlled. As demonstrated in Chapter III, various
nano-architectures could be built up using M I3 virus, and the virus templated gold
nanowires and nanoparticle arrays could be further utilized for electronic devices.
Biosensors
Biological templates, which possess predominant properties such as molecular
recognitions, ease of engineering, and self-assembly, could be integrated with the enzyme
immobilization techniques to produce enzymatic electrodes for biosensors. To construct
an effective biosensor, an enzyme targeting to specific biomolecule needs to be
immobilized onto a current collector. Generally, this could be done by surface
functionalizations/modifications of conductive substrates and chemical conjugation of
enzyme onto the substrates. However, structural and molecular tailoring on the surface is
the key to direct the movement of electrons involved in the redox reaction of the enzyme.
In general, a biologicial sensor can be realized to detect targeted molecules by
mornitoring and interpreting the shuttling of the electrons or the electrochemical potential
differences between the immobilized enzyme and the electrode.
Virus-based nanoelectrodes
M13 bacteriophage has a high aspect ratio structure and programmable
functionalities, which can benefit the fabrication and performance of sensors. The high
aspect ratio increases the density of enzyme that can be conjugated to the electrode
surface, and the controllable functionalities can easily hybridize enzyme and conductive
nanomaterials on the virus.
Glucose oxidase
Glucose oxidase (GOx) is a hydrogen peroxide-generating flavoprotein,
catalyzing the oxidation of P-D-glucose to D-glucono-1,5-lactone (gluconic acid). The
enzyme has been purified from Aspergillus niger and Penicillium amagasakiense. The
structural similarities between the enzymes derived from the two fungus strains are about
70%. Glucose oxidase from Penicillium amagasakiense has a higher turnover rate and a
better affinity to 3-D-glucose than its counterpart from Aspergillus niger. Glucose
oxidase is the most common enzyme used in biological sensor. Most recent researches for
building biological sensors focused on developing electron relays with artificial electron
acceptors or mediators used to shuttle electrons between the enzyme and the electrode.69
The electrical communication between glucose oxidase and the electrode is mainly
governed by the inert protein moiety of the enzyme. The performance of a biosensor is
controlled by the impedance of electron relay, when electrons tunneling from the active
site through the enzyme glucose oxidase to the electrode. In this thesis, glucose oxidase
was chosen as the standard enzyme to be conjugated on the virus for making glucose
sensors.
IV.C. Experimental
IV.C.I. Preparation of apo-glucose oxidase
Materials. Aspergillus niger glucose oxidase was purchased from ICN Biomedicals, Inc.
Four types of sodium phosphage buffer were prepared as follows: 1) 25mM sodium
phosphate (Mallinckrodt), pH=6.0 with 30% (w/v) glycerol; 2) 25mM sodium phosphate-
H2SO 4, pH=l.1 with 30% (w/v) glycerol; 3) 0.1M sodium phosphate, pH=1.7 with 30%
(w/v) glycerol; 4) 0.1M sodium phosphate, pH=7.0. And, dextran-coated charcoal
mixture made of 4ml of 0.4M sodium phosphate, pH=8.0, containing 20 mg of dextran
(TCI America) and 600mg of activated charcoal (Darcof' G-60, Sigma-Aldrich) was
prepared. And, Sephadex G-25 (Amersham Bioscience) was packed in a titration column.
Procedure. 75 mg/ml solution of the glucose oxidase in 30% (w/v) glycerol in 25 mM
sodium phosphate, pH = 6.0 was prepared. The exact enzyme concentration can be
calculated from 450 nm using the millimolar extinction coefficient 14.1 M-'cm-'. The
next step was acid-dissociation. Glucose oxidase solution 3 ml (or 6 ml) containing 0.225
g (or 0.450 g) of enzyme was stirred in a salt-ice bath, and ice-cold 30% (w/v) glycerol in
25 mM sodium phosphate-H 2SO 4, pH =1.1, was added until the whole solution reached
pH = 1.7. This should require about an equal volume of reagent. The mixture was then
incubated for 30 min at 00C. The mixture was loaded onto a column of Sephadex G-25
equilibrated with 30% (w/v) glycerol 0.1 M sodium phosphate buffer, pH = 1.7,
maintained at 40C. The column was eluted with the same medium at a flow rate of 9
ml/min. The samples containing the protein were combined and were added with
Dextran-coated charcoal. The elution of the apo-enzyme was monitored by its
transmittance at 280 nm. The molar extinction coefficient of a 1% (w/v) solution at 280
nm is 13.8. FAD concentration was monitored at 450 nm with extinction coefficient of
11.3 mMl cm-1.The pH of the collected solution was adjusted to 7.0 by slowly adding IN
NaOH. The collected solution was stirred for 1. hr at 40 C. The resulting solution was
centrifuged (at 3400 rpm for 5 min) and filtered through a 0.45 tm filter. At this stage the
apo-enzyme is stable to be stored at 40 C in a short-time. The solution was dialyzed
against a 0.1 M sodium phosphate buffer, pH = 7.0. At this stage the apo-glucose oxidase
in lyophilized form was quite stable and might be maintained at 40 C for at least 18
months without loss of activity. The absorption at 280 nm of 1.71 was for a 1 mg/mL
solution. The produced apo-glucose oxidase was further verified using MALDI mass
spectrometry. The final concentration of apo-glucose was adjusted to 5 mg/mL.
IV.C.2. Chemical conjugation of glucose oxidase (GOx) onto virus-based nanowires
Materials. The co-enzyme of glucose oxidase, flavin adenine dinucleotide (FAD) was
prepared in phosphate buffered saline (PBS, 0.1 M, pH 7.0) to make 10 mM solution. The
beta-D-glucose (ICN Biochemical Inc.) used for electrochemical test was dissolved in
PBS to make a serial concentrations ranging from 5 mM to 100 mM. Glutaraldehyde
(50%) purchased from Sigma-Aldrich was diluted in water to make 1% solution.
Immobilization of GOD. The Ml 3 bacteriophage was anchored on the gold substrate
and then mineralized with gold to form gold nanowire. 100 pL of FAD solution in PBS
was incubated with the substrate for 10 min, followed with the addition of 10 pL
glutaraldehyde (1% in water). The mixed solution was pipetted up and down and
incubated for 30 min. After removing the solution, the substrate was rinsed with I mL
PBS 5 times. The gold substrate was then incubated in I mL apo-glucose oxidase
solution overnight.
Cyclic Voltammetry. The gold substrate grafted by GOx-conjugated virus nanowires
was welded to the copper wire for connection to the potentiostat (Autolab, Model:
PGSTAT 30). Silver/silver chloride electrode was used as the reference electrode.
Platinum mesh was used as the counter electrode. The cyclic voltammetry was operated
at 5 mV/s from -0.1 V to 0.5V. The calibration line was plotted at 330 mV.
IV.C.3. Display of glucose oxidase on M 13 bacteriophage
Materials. Penicillium amagasakiense fungus was purchased from American Type
Culture Collection (ATTC# 28686). The sample was rehydrated with 880 uiL sterilized
water and transferred to a falcon tube containing 6 mL sterilized water. The fungus was
vortexed until the pellet was fully suspended. The rehydrated fungus was incubated at
25 0 C without shaking overnight. 12 g potato dextrose broth (PDB, from HiMedia
Laboratories, Pvt. Ltd.) was dissolved in 500 mL Milli-Q " water and autoclaved. The
designed primers were synthesized by Integrated DNA Technologies and diluted to 100
uM. Expand long template PCR buffered solutions and enzyme mix (Expand Long
Template PCR System) were from Roche Applied Science. VentR: DNA polymerase was
purchased from New England Biolabs. Deoxynucleotide solution mix (dNTP) was from
Invitrogen.
Extracting ds-DNA of Penicillium amagasakiense. 60 mL PDB was inoculated with 50
,uL rehydrated fungus solution in a culture flask. The fungus culture was shaked at 100
rpm at 250 C for 48 hrs. The culture was filtered with filter flask (0.2 uim pore size). The
fungal cake was sandwiched by clean filter papers to remove the remaining water. The
amplified fungi can be stored in 40 C for 6 months at this stage. To extract the DNA of the
fungus, the fungal cake was dipped into liquid nitrogen and grinded using mortar and
pestle. DNeasyR Plant Mini Kit (Qiagen) was used to complete the extraction and
purification of the double strands fungal DNA (ds-DNA).
Cloning and mutagenesis of glucose oxidase gene. The ds-DNA of Penicillium
amagasakiense extracted was used to clone the gene for glucose oxidase. Two cloning
primers were designed to replicate the GOx gene in Penicillium amagasakiense. The
sequence of GOx-273L was 5'- TTGCAATCCCGTTTACCTTC -3', and that of GOx-
2158R was 5'- ACCGCGATTCATGACACCT -3'. The PCR reaction was carried out as
follows:
H20 32.9 itL
dNTP (2.5 mM) 7 tL
GOx-273L (100 tM) 2 pL
GOx-2158R (100 ttM) 2 ýtL
Fungal ds-DNA (- 70 ng/tl) 0. 1 ýL
10X Expand long template buffer 1 5 ttL
Expand long template enzyme mix (5 U/tl) 1 tL
, and the PCR cycling condition was
1 cycle 94 0C
10 cycles 94 0C
48.2 0C
68 0C
25 cycles 940C
48.2 0C
68 0C
1 cycle 680C
I cycle 40C
2 min
10 sec
30 sec
2 min
10 sec
30 sec
2 min + 20sec/cycle
7 min
forever
The cloned GOx gene was 1886 bases long and purified with 1% agarose gel
electrophresis at 100V. Site-directed muntagenesis were used to create Sfi I restriction
stie on each ends of this GOx gene. Two primers containing overhangs were designed for
the muntagenesis PCR of the wild-type GOx gene sequence:
LPrimer GOx Sfil: 5'-CATGCGGCCCAGCCGGCCATGGCGGCAATGGTGTCTGT
ATTTCTCAGCACTCTTCTTTTA-3'
and RPrimer GOx #9 SfiI: 5'- CCATTTTGGATGACTATGCCAAAAGTGCCGGAG
GTGGATCAGCAGTGTCGGGGTCGTCGCCGGATTCGGATCCCGGCC AGGGAGG
CCAGAATATG -3'
The details of mutagenesis PCR reaction is shown as follows
H2O
dNTP (2.5 mM)
LPrimerGOx_SfiI (100 CIM)
RPrimerGOx_#9_Sfil (25 ,tM)
1.8 kb GOx ds-DNA (- 10 ng/tl)
10X ThermoPol beaction buffer I
Vent'" PCR Polymerase (2 U/dl)
35 ,uL
3.5 uL
1 uL
4 ,tL
0.5 uL
5 ,uL
I1 ,L
The mutagenesis PCR was carried out under the following conditions:
1 cycle 94 0C
10 cycles 940C
550C
720C
25 cycles 940C
550C
720C
1 cycle 720 C
I cycle 40C
2 min
10 sec
30 sec
2 min
10 sec
30 sec
2 min + 20sec/cycle
7 min
forever
Sfi I restriction stie was created on each end of the mutant DNA containing p8#9 motif
following the GOx gene sequence. The DNA product was confirmed by sequencing.
Engineering of phagemid with GOx. This mutant GOx gene and anti-phagemid vector
(engineered by Dr. Beau Peelle) were then digested with Sfi I restriction enzyme under
the following condition:
ds-DNA (- 100ng/pl)
H20
10X NE Buffer 2
100X BSA
Sti I (20U/,l)
10 uL
33.5 ,tL
5 uL
0.5 itL
1 ,tL
The digestion reaction was carried out at 500 C for 3 hours. After purifying the digested
products, GOx gene was ligased into anti-phagemid vector, which contains two Sif I
restriction sites in gene VIII. The ligation was carried out using T4 Ligase at 160C
overnight.
Amplification of GOx displayed M13 bacteriophage. The ligated DNA was cleaned up
using QlA quick PCR purification kit and electroporated into XL-l Blue
electrocompetent cell at 1.7 kV. The transformed cell was grown in S.O.C. medium at
370 C for 20 min. Antibiotic screening was used to select successfully transformed cell,
which contained ampicillin-resistant gene in the electroporated phagemid/plasmid. The
cells were stored in 50% glycerol at -800 C. The sequence of phagemid was confirmed by
DNA sequencing. Helper phage with specific pVlII and pill proteins would be used to
infect the bacteria harboring the phagemid containing GOx gene, displaying glucose
oxidases on the pVIII proteins of the amplified M13 bacteriophage. The amplification
was carried out using regular procedures to amplify type 8+8 or type 8+8-3 virus.
Protein electrophoresis and enzyme assay. The protein electrophoresis analysis was
carried out using 16% Tris-Glycine SDS-PAGE gel. To perform the enzyme assay, a
mixture of 2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS, 0.5mM) and
horseradish peroxidase (HRP, 25 U/mL) was prepared. For each assay, 100 pgL mixture
was mixed with 100 pL of beta-D-glucose (I M) and 10 tiL phage. 10 tiL water instead of
phage was used for the negative control, and active glucose oxidase solution was used for
the positive control.
IV. D. Results and Discussion
To build a biosensor, sensing molecules and conductive materials need to be
bridged and be able to communicate each other. The scheme was to display an anti-gold
peptide in the pVIII protein of phage and covalently bond the N-terminus of pVIII protein
to the enzyme. The anit-gold peptide was to create gold coating on the virus surface. The
gold coating on the virus acted as an electron collector to direct the electrons out of the
enzyme. The next goal was to pattern the viral electrode onto the substrate, by
engineering the pIII protein to bind to the substrate. Before immobilizing glucose oxidase
(GOx), the MI3 bacteriophage was first conjugated with the co-enzyme, FAD, through
the amine terminus on the pVIII protein. This step was to assure the placement of redox
site in the enzyme would be close to the conductive nanoparticles grown on the virus.
The apo-enzyme, apo-glucose oxidase, was then reconstituted onto this virus template.
TEM images showed the apo-enzyme was immobilized onto the surface of the FAD-
conjugated MI3 virus (Figure 1).
The next step was to conjugate the enzyme onto the viral gold nanowire, which
served as the electron relay between the enzyme and the current collector (substrate).
Covalent coupling techniques were chosen to immobilize redox-enzymes onto pVIllI
proteins on the bacteriophage. For the first time, glucose oxidase was integrated into this
viral nanowire system. After nucleating gold onto the pVIII proteins by the method
described in Chapter III, the coenzyme of glucose oxidase, flavin adenine dinucleotide
(FAD), was immobilized onto the virus through the free amine groups on pVII proteins.
Apo-glucose oxidase was therefore reconstituted onto the phage through the FAD.
Individual engineered virus particle now could serve as an enzymatic nonoelectrode as
schemed in Figure 2.
The type 8-3 virus was engineered with the anti-gold peptide motif, p8#9, on
pVIII protein and the distinct anti-gold peptide (under the reduced from of pIII protein),
p3-Au7C I r, on pllI protein. To avoid the aggregation of enzymatic nanoelectrodes and to
test the activity of the enzyme reconstituted on the bateriophage surface, the virus was
anchored onto a gold substrate as described in Chapter II, and then immobilization and
reconstitution of the enzymes were carried out on the viruses by using the described
methods in this chapter. Atomic force microscopic (AFM) images showed filament and
particle patterns, indicating the surface modifications by the hybrid structures of enzyme,
gold nanoparticles and M13 virus (Figure 3). Cyclic voltammetry (CV) was measured
using potentiostat to examine the built electron relay. The results showed that this virus-
based electrode exhibited the oxidative peaks of glucose catalyzed by glucose oxidase at
-350 mV (vs SSCE). The measured currents and calibration line of the virus-based
electrode operated at 330 mV was plotted in Figure 4. This amperometric glucose sensor
operating at 330mV showed detectable currents when the surrounding glucose
concentrations ranged from 5 mM to 100 mM. The current density of this virus-based
electrode was approximately 0.1 mA/cm2 at 50 mM glucose. The performance of an
enzymatic virus electrode may be optimized by increasing the amounts of enzyme
immobilized on the virus, changing the alignments of viral nanoelectrodes, or altering the
electron relay structures between the enzyme and viral nanowire.
The incorporation of enzyme and biomineralization using a virus template also
could be achieved by directly displaying a enzyme onto the pVIII protein of the virus. To
date, Penicillium amagasakiense glucose oxidase was the only one successfully
expressed in a prokaryotic host.7" Since the bacteriophage is assembled in the bacterial
cell, Penicillium amagasakiense glucose oxidase was chosen for the direct protein
expression on the phage. The glucose oxidase genome was cloned from Penicillium
amagasakiense using primers containing mutation sites to generate the Sfi I restriction
sties on both ends of the GOx gene. This gene was then ligased into the anti-phagemid
vector containing two Sfi I restriction sites in the gene VIII, which was later transformed
into XL-1 Blue electrocompetent cells. The display of glucose oxidase on the virus was
confirmed using SDS-PAGE protein electrophoresis (Figure 5). The enzyme displayed on
the virus was reconstituted with FAD and tested for its activity using the enzyme assay.
The active glucose oxidase will oxidize beta-D-glucose and water to generate gluconic
acid and hydrogen peroxide. With the presence of hydrogen peroxide, horseradish
peroxidase (HRP) will oxidize the substrate, ABTS, to turn the solution from colorless to
green color. The enzyme assays were carried out with a serial dilution of GOx expressed
bacteriophage. However, the enzyme showed no activity up to this point. A denature and
renature process was carried out to re-fold the enzyme. The GOx engineered
bacteriophage was denatured with 8 M urea for 10 min and then diluted with PBS
containing FAD 30-fold to re-nature it7l 72.The sample was then dialyzed using 12,000-
14,000 MWCO membrane in PBS and concentrated after the dialysis. The enzyme assay
still showed negative result. Further investigations are required to improve the enzyme
expression and reactivation.
IV. E. Conclusion
The incorporation of these two techniques, the growing of conductive material
and the immobilization of enzyme on the pVII protein in bacteriophage, could be used to
build electron relays between enzymes and viral nanowires. This enzymatic virus
nanoelectrode potentially functions as an electrode for bio-energy generation or bio-
sensor. The most attractive characteristics of using M 13 bacteriophage as the template is
that the enzyme could be directly displayed onto the virus. The viral template hence
serves for two purposes: one is to serve as the biominerization scaffold to bind inorganic
materials, and the other is to serve as the platform to grow/express biological reactors,
such as enzymes. Although the preliminary results did not show active enzymes to be
directly displayed on the bacteriophages, a feasible novel device design was proposed
and demonstrated. Future researches on the direct display of enzyme will help to realize
the engineering scheme described in this chapter.
IV. F. Figures
Figure 1. TEM images of glucose oxidase coated virus nanowires. Co-enzyme flavin
adenine dinucleotide (FAD) was chemically linked to the virus and apo-glucose oxidase
was then reconstituted onto the virus.
3lucose
Gluconic Acid
Figure 2. Schematic representation of glucose oxidase conjugated M13
bacteriophage. The glucose oxidase (GOx) was reconstituted onto the flavin adenine
dinucleotide (FAD) to ensure the orientation of enzyme. FAD was used to bridge GOx
and the virus.
Gold substrate Immobilized with virus Immobilized with gold
particles and enzyme
Figure 3. Enzymatic glucose oxidase electrode. A wired gold substrate was
immobilized with gold-binding virus. After conjugating the virus with flavin adenine
dinucleotide, the apo-enzyme was reconstituted on the surface.
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Figure 4. Electrical properties of glucose oxidase electrode. (a) Cyclic voltammetry of
of modified electrode was recorded in 0.1 M phosphate buffer (pH = 7.0) and at potential
scan rate 50 mV/s. (b) the calibration plot at 330 mV (vs SSCE) indicated that this
modified electrode could serve as an amperometric glucose sensor for monitoring the
range of glucose concentration from 5 mM to 100 mM.
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Figure 5. SDS-PAGE electrophoresis of glucose oxidase expressed virus. Lane 1 was
a protein standard (Mark 12TM). Lane 2 was p3-Au7Clr amplified in normal E. Coli
ER2738 culture. Lane 3 was p3-Au7Clr amplified in the phagemid engineered E.coli(anti-phagemid vectro containing glucose oxidase gene) with isopropyl 3-D-
thiogalactoside (IPTG), and lane 4 (negative control) was that without IPTG. The
phagemid contains the gene to produce glucose oxidase (GOx), and the assembly and
production of GOx was triggered by IPTG. The band of displayed GOx (- 72 kDa) on
M13 virus was highlighted by the red arrow.
Chapter V. Micro-fabrication of virus-based functional fiber
V.A. Summary
Despite the increasing need for material multifunctionality in optical and
semiconducting fibers, anti-microbial textiles, molecular filtration membranes, and
other applications, the production of functionalized fibers has posed a challenge in
materials science and engineering. In this chapter, the design and synthesis of fibers
with genetically controllable and functionalized surfaces using M13 filamentous
viruses are discussed. This work applies genetic engineering, chemical conjugation,
and biotemplating methods to produce continuous fibers of centimeter-scale length and
micrometer-scale diameter from nanoscale virus scaffolds. In addition, we find the
virus fibers to be mechanically comparable to synthetic homopolymer fibers. The
tunable fimctionalities and mechanical properties of the virus fibers show the promise
of these high aspect ratio structures as useful materials for various applications
including detection, catalysis, energy storage, and power generation.
V.B. Introduction
Issues in developing functional fibers
Increasing demand for tuning the molecular dimensions, structures, and
functionalities in nanoscience has driven the search for materials with precisely
controllable properties. Fibers are currently used in energy and electronic applications
to obtain high energy density, energy capacity, and transportation efficiency, which
may all be further improved by using nanostructured materials. 7 -7 Synthetic polymers
are commonly used as fiber materials;77' 78 however, since it is difficult to produce
varied functionalities on a single fiber surface, synthetic polymer-based fibers often
lack functional versatility. Surface modifications of synthetic fibers usually require
multistep chemical modifications and/or expensive enzyme treatments. 78-8 1 In addition,
due to the lack of control over molecular structures and conformations, mixing
incompatible functionalities in a material often leads to disorganized structures at the
molecular level or to micro- to macroscopic phase separation, resulting in unintended
or defective functionalities in the fiber surface.
Consequently, biological macromolecules such as DNA, proteins, and
microorganisms (e.g., virus and fungi) have become key materials design components
due to the inherent nanoscale control of molecular functionalities and structures. 82 86 In
nature, functionalities and hierarchical structures of fibrous proteins are precisely
controlled by DNA and widely used to make strong and functional fibers such as
spider silk"7-89 and collagen.9o However, these natural proteins are already highly
evolved for specific functions, and it is difficult to engineer new design parameters into
them. By adopting and combining the principles of fabrication found both in nature
and in laboratories, the building blocks with desired functionality and structural
hierarchy at the nanometer level can be designed and further these building blocks can
be assembled into continuous and mechanically robust fibers.
Fibers made of filamentous virus
The ease of modifying M1I3 makes this virus an attractive platform for the
growth and assembly of a variety of materials. At sufficiently high concentrations,
M13 viruses behave as lyotropic liquid crystalline mesogens and self-organize to form
micrometer-scale long-range order in aqueous solutions. 91, 92 The liquid crystalline
property of M13 is driven by its high aspect ratio and anisotropic. polarity. Inspired by
the synthesis routes and properties of natural fibers,93 viral liquid crystalline solutions
were used to fabricate virus-based fibers. Here, the goal was to fabricate genetically
functionalized fibers by spinning engineered M 13 viruses.
V.C. Experimental
V.C.1. Wet-spun virus fibers
Materials and equipment. M13 bacteriophage was amplified, purified and
concentrated to 1013 pfu/pL. The crosslinking agent (glutaraldehyde, 50%) was
purchase from Sigma-Aldrich. The spinning speed is controlled by Pump 22 Multiple
Syringe Pump (Harvard Apparatus). The 33 gauge needles were purchased from
Hamilton Co.
Wet-spinning procedure. A concentrated virus solution (- 470 mg/mL in Milli-Q®
water, 1.7 x 1013 pfu/pL) was spun vertically through the needle into a glutaraldehyde
solution by a syringe pump at a constant speed of 0.025 mL/hr, producing
approximately 13 cm of virus fiber per pL of viral suspension. After incubating in
glutaraldehyde for 2 hrs, virus fibers were rinsed with Milli-Q® water. These fibers
were then vertically pulled out of the water by forceps and dried in air.
V.C.2. Chemical conjugation of nanoparticles onto virus
Materials. Qdot" 705 ITKTM amino quantum dots were purchased from Invitrogen
Corp. 1-Ethyl-3-(-(3-Dimethylaminopropyl) carbodiimide Hydrochloride (EDC) was
from BD BioSciences.
Chemical conjugation. To conjugate quantum dots to M13 viruses, 5 pL EDC (200
mM) was added to 200 1pL virus solution (- 5.5 x 10" plaque forming unit or pfu/!L in
Milli-Q® water), which was mixed with 5 [L quantum dot (QD) solution (8.25 jpM).
The mixture was vortexed and incubated at room temperature for 1.5 hrs. After adding
40 gLL PEG/NaCl solution (20% (w/v) polyethylene glycol-8000, 2.5 M NaCl), the
mixture was centrifuged at 10,000 rpm for 10 mins. Unbound QDs in the supernatant
were removed, and the virus pellet was re-suspended in 10 pL Milli-Q® water.
V.C.3. Biomineralization of functional virus fibers
Materials. Virus fiber spun in 2.5% crosslinking solution. HAuCI4 (chloroauric acid)
and NaBH 4 (sodium borohydride) were purchased from Sigma-Aldrich.
Biomineralization. To test the gold mineralization capability of fibers, the wet fiber
was immersed in a 300 gtL chloroauric acid solution (5 mM, pH 7.5) and incubated on
ice for 10 min. A 150 4L sample of ice-cold sodium borohydride solution (5 mM) was
then added to reduce the gold. After 12 hrs, the fiber was manually removed from the
solution, rinsed with Milli-Q ' water, and dried in air.
V.C.4. Instrumental analysis on virus fibers
Microscopy and energy dispersive X-Ray characterization. Polarized optical and
fluorescence microscopy images were obtained using an optical microscope (Olympus
IX51). SEM images were analyzed with FEI/Philips XL30 Field Emission Gun
Environmental Scanning Electron Microscopy (FEG-ESEM), operated at 10 kV with an
electron backscattering detector. Energy dispersive X-ray (EDX) images were collected
at a resolution of 256 x 200 pixels with 256 frames.
Uniaxial tension test. Under dry conditions, the ends of each fiber were secured between
two stainless steel shims coated with cyanoacrylate, and the uniaxial tension tests were
performed using 8848 Micro Tester (Instron Corp.) at ambient temperature, humidity,
and pressure. Strain was recorded as crosshead displacement measured via a digital
optical encoder within the load train.
Bending stiffness test. The fibers were mounted as end-clamped cantilevers and fixed at
one end with cyanoacrylate at the edges of glass slides. A scanning probe microscope
(3D-Molecular Force Probe, Asylum Research) was used to acquire the force-
displacement response of the fibers via deflection of silicon nitride cantilevers (OMCL-
AC160TS, Olympus Corp.). The optical lever sensitivity of the silicon nitride cantilevers
was 41.64 - 47.35 nm/V and the spring constants k calculated from the thermal vibration
spectrum were 59.25 - 71.36 N/m. Bending stiffness measured at different force
application points can be interpreted to obtain the Young's modulus E of the virus fiber
and the x' using the nonlinear relation:
P 3EI
d (X + x') (1)
where I is the moment of inertia of the cylindrical fibers. In Equation (1), d is the free-
end displacement of a cantilevered fiber when it is subjected to a force P, x is the distance
from the application point to the reference point. x' is the distance from the reference
point to the support, and the moment of inertia I equals to D4/64 for a cylindrical fiber of
diameter D.
Error analysis. The dimensions of the fiber and the resolution of the uniaxial tensile
apparatus were the dominant sources of error in the mechanical properties measured here.
The resolution of the uniaxial tensile apparatus is 0.1 pm in displacement and 10 nN in
force. The suspended length of the fiber was measured using a digital caliper with an
error of 0. 1 %, and the fiber diameter was measured using optical microscopy with an
error of 5%. For scanning probe microscope (SPM) bending experiments, the SPM
system calibration had 3% error for both optical lever sensitivity and cantilever spring
constant k. The linear fit of the uniaxial stress-strain response with an error of 1% and the
nonlinear fit of the SPM stiffness-position response with an error of 3% were calculated
using Microcal Origin". For each experimental variable, five specimens were tested via
uniaxial tension or via nanoscale bending test.
Thermal gravimetric analysis. Thermal gravimetric analyses were acquired using
GTA7 Thermogravimetric Analyzer (Perkin Elmer). TGA samples were preheated to
100'C and held for 5 min. After cooling down to 400 C at 200 C/min, samples were heated
from 40 0 C to 6000 C at 5'C/min.
V.C.5. DNA extraction
Materials. Premixed solution of Phenol : Chloroform : Isoamyl Alcohol (25:24:1) and
water-saturated ether were prepared. Phenol was purchased from Fluka, chloroform,
isoamyl alcohol and ether were purchased from Sigma-Aldrich. Four sequencing primers
designed to PCR inserted peptides on pVIII were synthesized by Integrated DNA
Technologies. 1164Lprimer was 5'-TGTACTTTGTTTCGCGCTTG-3', 1339Rprimer
was 5'-AACGGCTACAGAGGCTTTGA-3', #9g8Rprimer was 5'-CGAATCCGGCGA
CGA-3', and KEg8Rprimer was 5'-CGGGATCGTCACCCTCAG-3'. Deoxynucleotide
solution mix (dNTP), polymerase, and PCR reaction buffer were from New England
Biolabs.
Phenol Extraction. A piece of viral fiber (abou 5 - 10 mm) was mixed with 50 pL
phenol solution (premixed with chloroform and isoamyl alcohol). The sample was heated
up to 90'C for 2 min and then cooled down to room temperature. 50 gtL of water was
added and the sample was vortexed for 5 min. The sample was centrifuged at 6,000 rpm
for 5 min. The upper aqueous layer was transferred to a fresh sample tube. The aqueous
solution was added with 50 ýtL water-saturated ether, vortexed, and centrifuged at 6,000
rpm for 4 min. The upper layer (ether) was discarded. The ether cleaning step was
repeated three times. The final extract was vacuumed for 10 to 20 seconds to vaporize
remaining ether.
PCR of extracted DNA in the fiber. The PCR condition was described as follows:
H20
DNA extract
1164Lprimer (100 ýtM)
Rprimer (100 ,M)
dNTP (10 mM)
10X Polymerase Buffer
Taq'ý Polymerase (5 U/pl)
43 LtL
5 uL
20 LtL
20 LtL
I uL
10 ttL
1 uL
And, the cycling condition was:
I cycle 94 0C 2 min
20 cycles 94 0C 15 sec
490C 15 sec
72 0C 45 sec
I cycle 72 0C 5 min
1 cycle 40C forever
Electrophoresis. The PCR products was purified and quantified using 2% Agarose gel
electrophoresis containing ethidium bromide running at 90V. 25 bp DNA Ladder
(Invitrogen) was used as the standard.
V.D. Results and Discussion
Two synthetic routes to fabricate virus-based functional fibers were demonstrated: i)
biotemplating the viruses with desired functionality before spinning the viruses into
fibers; ii) spinning evolutionally selected and genetically modified viruses into fibers or
outer sheaths of fibers for subsequent biotemplating.
For the former case, amine-terminated cadmium selenide quantum dots (QD) were
chemically conjugated to MI3 virus templates via the carboxylic acid side groups
displayed on the pVIII proteins. A continuous fiber of micrometer-scale diameter (micro-
fiber) was created through a wet-spinning process where a concentrated QD-conjugated
virus solution was spun vertically into 2.5% glutaraldehyde solution at a constant rate.
The virus fibers containing QDs emitted red light under exposure to ultra-violet light
(Figure la and b). This demonstrated that conjugated quantum dots could be retained in
virus fibers after the wet-spinning and washing processes. These quantum dot/fiber
assemblies might serve as optical devices and advanced sensors. 94 To adjust the optical
performance of a virus fiber, increasing the displayed copies of carboxylic acid side
groups on pVIII proteins may result in relatively higher quantity of QDs to be conjugated
to the virus. To demonstrate this surface tunability, a genetically engineered glutamate-
rich virus, named E4, was used for QD conjugation. This virus contains four glutamates
(Glu) and one aspartate (Asp) in the outer six amino acids at the N-terminus of the pVIlI
protein. Compared with the wild-type M13KE virus, E4 has two additional glutamates in
the outer part of each pVIII protein and therefore exhibits increased conjugation of
amine-terminated QDs (Figure 1c). This experiment demonstrated that genetic
engineering is essential to improve or tune the bio-templating properties.
For the latter fabrication route, the capability of surface-functionalized M13 virus
to make self-supported or composite functional fibers for subsequent biotemplating of
gold was demonstrated. The peptide sequence Val-Ser-Gly-Ser-Ser-Pro-Asp-Ser
(VSGSSPDS), termed p8#9, was selected from screening a type 8 bacteriophage library
on gold substrates (see Chapter II). Genetically modified MI3 virus containing p8#9
peptides has been shown to act as a template for growing gold nanowires and gold nano-
particle arrays in Chapter III. Through genetic engineering, bacteriophage building blocks
provide flexibility in designing and modifying the fiber surface (Figure 2).
Continuous micro-fibers were produced using the same wet-spinning process
described above. After the virus fibers were rinsed with water to remove unreacted
glutaraldehyde, gold nanoparticles were directly nucleated from aqueous Au 3- solutions
upon reduction via sodium borohydride (NaBH4), resulting in nanoparticles which bound
specifically to the engineered virus fibers at room temperature (Figure 3). The fiber
surface and the distribution of biotemplated gold on the virus fibers were analyzed using
scanning electron microscopy (SEM) and energy dispersive X-ray imaging (EDX). The
homogeneous coating of gold nanoparticles on the genetically functionalized p8# 9 fibers
indicated the correct presentation of functionalities on the virus fiber surface (Figure 4a).
To demonstrate specificity of this gold-binding on genetically engineered M13
virus fibers, fibers were also spun from a wild-type clone, M13KE, which does not
contain the gold-binding functionality. These control fibers contained discrete and
scattered gold islands on the fiber surfaces after the identical processing for the p8#9
fibers (Figure 4b). Although the surface roughness of virus fibers provides high surface
tension, which may be expected to facilitate non-specific binding of gold particles onto
the fiber, the M I3KE fiber itself still exhibited low gold-binding affinity. This resulted in
a low density of gold on the M 13KE fiber surface.
The ability of Kevlar"` fibers to bind gold was also explored. These synthetic
homopolymer fibers showed a negligible amount of gold deposition (Figure 4c). Absence
of binding affinity to gold and the smooth surface of these synthetic fibers resulted in
poor adhesion of gold particles. To create multifunctional fibers having high mechanical
strength and capability of surface mineralization, a core-sheath structure was achieved,
using Kevlar" as the core material and the engineered virus as the sheath. A Kevlar' fiber
was dipped into a minimally crosslinked gold-binding virus suspension containing 0.05%
glutaraldehyde. Both KevlarR and the virus contain functional groups in their chemical
structures that can participate in secondary forces, such as hydrogen bonding and
hydrophobic interactions, resulting in adhesion between Kevlar ": and the virus. This
virus-coated Kevlar" fiber was then transferred to a 2.5% glutaraldehyde solution to
continue the crosslinking reaction. After coating with this gold-binding virus, gold
nanoparticles were templated directly onto the composite fiber (Figure 4d).
Although agents such as glutaraldehyde will crosslink the amine groups at the N-
termini of pVIII proteins, no disruption of surface functionality of the M I3 viruses in
these fibers was observed. This demonstrates the capability of the genetically engineered
nanometric virus scaffold to mineralize inorganic materials at ambient temperature and to
retain the desired functionality when assembled as micro-fibers. Such micrometer-sized
fibers containing nanoparticles may be used in catalytic filtration, battery electrodes, and
photovoltaic devices." 9.
The reproducible dimensions and structures of these centimeter-long fibers enabled
us to study the mechanical properties of virus fibers for the first time. Although reports
discussing the mechanics of protein-based natural fibers have been reported,97' 9" the
mechanical properties of virus-based fibers have not yet been considered. To evaluate the
practical applications of such functional fibers, the elastic modulus, yield and ultimate
tensile strength, failure stress and strain, and strain-rate sensitivity of the virus fibers were
measured. To verify the effects of the virus crosslinking density on the fiber mechanical
properties, virus fibers were synthesized in various concentrations of glutaraldehyde
ranging from 0% to 10% (v/v). The estimated spinning rate was 5.3 cm min- for all
concentrations tested. A change in the liquid crystalline phase during fiber spinning was
expected to directly affect the mechanical properties of the virus fibers due to the
orientation of the viral particles. Thus, all the virus fibers were spun from nematic liquid
crystalline solutions to avoid variation resulting from different liquid crystalline phases.
No fiber was formed in the absence of crosslinking agent; the fibers spun into 0. 1%
and 0.5% glutaraldehyde were diffuse and semitransparent; and the fibers spun into
crosslinking agent of > 1% were solid and opaque (Figure 5). The diameters of the fibers
varied from 10 to 50 utm depending on the spinning rate, the %-glutaraldehyde, and
L. - L1
elongation ratio (--------L x%, where Li is the initial length of fiber spun from theLi
spinneret in the wet state and L/ is the final length of fiber in the dry state). All the fibers
could be pulled out of the solution by forceps, indicating sufficient strength for
mechanical processing such as drawing and weaving.
Uniaxial tensile tests were conducted to examine the mechanical properties of these
virus fibers in the dry state (Figure 6). On average, engineering stress-strain responses of
pure virus fibers indicated a Young's elastic modulus E of- 3 GPa, an ultimate tensile
strength ,, of - 33 MPa, and an ultimate tensile strain c,,,~ of - 1.3%. Overall, E of the
pure virus fiber was similar to that of Nylon 6,6 (E = 1 - 3 GPa) and glassy
homopolymers such as polystyrene (E = 2 - 4 GPa). Fiber ultimate tensile strength ua,
was comparable to that of atactic polystyrene and poly(tetrafluorethylene) (a,,= 15 - 50
MPa). The normalized tensile strength (a,i,/E) of the virus fibers (0.005 - 0.030) was
bounded by that of Nylon 6,6 (0.02 - 0.06) and polystyrene (0.002 - 0.02), indicating
that the mechanical strength of virus fiber is similar to common synthetic (and glassy)
homopolymers (Figure 7).
Mechanical data were analyzed statistically using one-way ANOVA (analysis of
variance). When varying the crosslinker concentrations in the processing, statistically
significant changes occurred in stiffness as quantified by E (F(4,20) = 2.919; F(x,.) is the
measurement of difference between individual distributions, where x is the degrees of
freedom for the between group, and y is the degrees of freedom for the within group,
probability p < 0.047) and effective ductility as quantified by c,,,, (F(4,20) = 4.966, p <
0.006); however, changes in a,, as a function of %-glutaraldehyde were not statistically
significant (F(4,20) = 0.9765, p < 0.44) (Figure 8). It is important to note that the
variation of measured mechanical properties is attributed to both the resolution of the
uniaxial tensile apparatus and the imprecise elongation of virus fibers during the drying
process, the latter of which affects the extent of fiber crystallinity, as discussed below.
The extent of elongation in the wet state and the crosslinking density of a virus
fiber will determine the %-crystallinity in the fiber and its mechanical properties. Virus
fibers fabricated from < 1% glutaraldehyde can be elongated 5 - 20% before drying in air.
The maximum E was observed for the lowest crosslinker concentration of 0.5%
glutaraldehyde. This is because the crosslinking density of the virus fiber determines the
degrees of freedom of virus orientation during the processing preceding drying. The
effects of virus orientation on fiber crystallinity were observed using polarized optical
microscopy (POM) (Figure 9). The crystallinity of the virus fibers with low crosslinking
density can be easily increased by elongating the wet fibers. This reorients the virus
particles and promotes secondary interactions among viruses. In other words, low
crosslinking density gives the fibers sufficiently high degrees of freedom for reorientation
of the virus particles upon extension in the wet state. Conversely, for the fibers with high
crosslinking density, the virus particles have limited degrees of freedom, resulting in a
lower degree of crystallinity even upon elongation of the virus fiber in the wet state.
An independent set of samples was tested under uniaxial tension and bending to
examine the effects of virus orientation on fiber mechanical properties. In this experiment,
oriented fibers were elongated at least 15% in the wet state and analyzed to measure E in
the dry state. In tension, we observed that E of the oriented virus fiber (3.13 ± 1.88 GPa)
increased significantly compared to the unoriented fiber (0.68 ± 0.39 GPa) and that the r,
of the oriented fiber (35.05 ± 25.53 MPa) also increased significantly with respect to the
unoriented counterpart (6.02 ± 5.40 MPa). The bending stiffness (force P normalized by
free end displacement d) of the same set of samples was also measured using a scanning
probe microscope (SPM) at different force application points (x+x') along the
cantilevered virus fiber (Figure 10). The elastic moduli E acquired via this method were
0.98 ± 0.74 GPa and 3.15 ± 1.54 GPa for non-oriented and oriented virus fibers,
respectively, which agreed well with that measured via uniaxial tension. We therefore
conclude that the crosslinker is only needed to process the virus fibers via spinning but
not necessary to enhance the mechanical properties of virus fibers. In the case of virus
fibers with low chemical crosslinking densities, both the mechanical strength and
stiffness is attributed to the secondary inter-viral interactions such as hydrogen bonds and
ionic interactions, and the mechanical properties can be enhanced through fiber
elongation that promotes crystallinity via environmentally benign processing.
To evaluate the extent of viscoelasticity in the virus fibers, uniaxial tensile tests
were conducted at three different displacement rates: 10-2, 10-3 and 10-4 mm sec -,
corresponding to strain rates f of 10-1 to 10-3 sec'- (Figure 11).A slight increase in E
(F(2,12) = 4.974, p < 0.027) and decrease in Ea,,,. (F(2,12) = 27.78, p < 0.0001) were
observed as a function of i . For a 100-fold increase in strain rate, E increased only by
1.5-fold. This indicates that the virus fibers are well approximated as linearly elastic
materials. In addition, no statistically significant change in c,, (F(2,12) = 0.8042, p < 0.47)
was observed over this strain rate range. Neither necking nor significant plastic
deformation prior to fracture was observed under uniaxial tension (Figure 6), and the
fracture surfaces appeared globally brittle (flat and normal to the loading axis) under
optical microscopy (Figure 11). However, scanning electron microscopy images showed
locally ductile fracture features (< I [tm in length and < 20 nm in width) across the whole
fracture surface of the virus fiber (Figure 11). The fracture surface was perpendicular to
the loading axis and was microscopically rough because of this localized pullout of virus
materials. Thus, the mechanical failure of these virus fibers appears macroscopically
brittle and microscopically ductile, consistent with the hydrostatic stress-sensitive failure
surface of brittle polymers.
After nucleation of gold nanoparticles on the virus fibers, E decreased to 0.2 - 1.5
GPa, due most likely to the chemical and physical deterioration caused by the reducing
agent and the formation of gold inside the fibers. This deterioration may be avoided by
employing a milder reduction reaction for gold, such as hydrogen reduction. On the other
hand, the composite fiber with a core-sheath structure maintained structural integrity
upon gold nucleation: E of Kevlar" fibers before virus functionalization was - 35 GPa,
and remained unchanged after gold was mineralized onto the composite fibers (- 33 GPa).
This indicates that viruses can serve as a functional template to alter the functionality of
Kevlar" fibers without any chemical or mechanical deterioration of the overall fiber
mechanical properties.
Thermal gravimetric analysis (TGA) showed that both non-coated and gold-coated
virus fibers exhibit thermal stability up to 190 0 C (< 5% weight loss) in nitrogen.
Substantial degradation initiated at - 260'C. Residual char was > 30 wt% for the
uncoated virus fiber and > 60 wt% for the gold-coated fiber (Figure 12). Therefore, the
amount of gold coated on a virus fiber was -· 30 wt% with respect to that of the uncoated
virus fibers. Both non-coated and gold-coated virus fibers were more stable in air than in
nitrogen at the high temperature range between 300'C and 500'C, where the thermal
degradation was delayed in the presence of oxygen (Figure 12). This is due to the
interaction of oxygen with nitrogen and phosphor atoms, which exist in the viral DNA as
well as in the coated proteins and may act as flame retardants in the virus.
The viral DNA stored in the virus fiber exhibited long-term stability at room
temperature. The DNA could be extracted using phenol extraction as described in the
experimental session, and its integrity was verified using PCR, Agarose electrophoresis,
and DNA sequencing. Four primers were designed for PCR and sequencing.
1164Lprimer and 1339Rprimer, targeting gene VIII for 176 bp cloned DNA, were
universal primers for any type of M13 bacteriophage. #9Rprimer was designed for
targeting the M13 virus containing p8#9 gene in the gene VIII, producing 233 bp DNA.
KERprimer was used to target virus with the wild-type gene VIII, producing 225 bp
cloned DNA. The targeted DNA was varied from 176 to 233 base pairs depending on
the type of virus used to spin the fiber and the primer added during the PCR. The virus
fiber showed excellent preservation of the viral DNA. All the virus fibers used in the
DNA integrity test were left on bench at environmental temperature for more than 6
months. Agarose gel and DNA sequencing results showed that the DNA extracted
from the virus fiber remained its integrity (Figure 13). The virus fiber could be used as
a long-term storage device for preserv/ing DNA information at environmental
temperature without fridge or serving as a encryption material.
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V.E. Conclusion
This work provides a new conceptual scheme for fiber design and fabrication
through genetic modification of a biotemplate (Figure 14). Using an engineered virus to
continuously produce functional materials or coatings for synthetic fibers could simplify
current surface modification processes such as multistep chemical or enzymatic
treatments. The potential of the MI3 virus to serve as a powerful toolkit for designing a
specific functional fiber material from standard techniques including biopanning,
bacteriophage amplification, and genome modification was demonstrated in this chapter.
The virus fibers exhibit mechanical toughness and strength comparable to synthetic
polymer fibers, indicating that this filamentous virus can be integrated into current fibril
and woven mesh manufacturing systems. The genetic manipulation of diverse
functionalities on the virus fiber surfaces offers a convenient and powerful basis for
conjugating organic or inorganic materials for a variety of applications such as the
creation of anti-microbial, catalytic, optical, medical, and electronic materials.
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V.F. Figures
(a).
Figure 1. Images of chemically engineered functional fibers. (a) Fluorescence
microscopy image of E4 virus (a genetically engineered glutamate (Glu)-rich virus) fiber
conjugated with QDs excited by using UV light. (b) Under exposure to UV light, virus
fibers conjugated with QDs emitted red light (left) and nonconjugated virus fibers emitted
blue light (right). (c) The E4 virus (left) showed a relatively higher intensity of light
emission than the wild-type M13KE virus (right) after QD conjugation and purification.
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Figure 2. Schematic design of genetically engineered functional fibers. Schematic
illustration of an inserted DNA sequence displaying specific peptides (orange) along the
M 13 virus that is spun into a fiber with the desired surface functionality.
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Figure 3. Gold nucleation on virus fiber. (Left) A virus fiber was immersed in gold
precursor solution and added with the reduction agent to nucleate gold nanoparticles on
the fiber. (Right) The gold-coated virus fiber was rinsed with water to remove unbound
gold nanoparticles.
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Figure 4. Effects of genetic engineering on mineralization. SEM and EDX images, and
schematic representations of different types of fibers after gold mineralization. (a) Dense
gold nanoparticles are homogeneously mineralized on a fiber comprising viruses (p8#9)
selected to bind gold nanoparticles. (b) The M13KE fiber contains no specific gold-
binding affinity and exhibits a small amount of random binding to gold particles. (c) The
Kevlar fiber exhibits limited, if any, gold-particle attachment. (d) Nucleation of gold
nanoparticles is only observed on the portion of a Kevlar fiber coated with p8#9 viruses.
2.%1 .5 .%0
Figure 5. Images of virus fibers. (Top) Virus fibers fabricated in various glutaraldehyde
solutions ranged from 0% to 2.5%, indicated as vol%. (Bottom) A continuous virus fiber
(longer than 30 cm) fabricated in 2.5% glutaraldehyde in a petri dish.
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Figure 6. Uniaxial tension test. (Left) A virus fiber sandwiched by stainless shims was
mounted on the tensile tester before and after fracturing. Data was only collected when
the fracture occurred between the two mounting stainless shims. (Right) Representative
engineering stress-strain response of virus fibers. No plastic deformation was observed
until the fiber fractured.
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Figure 7. Bar-chart of normalized tensile strength (a./E) for selected natural and
synthetic polymers. The normalized tensile strength of the virus fibers was bounded by
that of Nylon 6,6 and polystyrene, indicating that the mechanical strength of virus fiber is
similar to common synthetic homopolymers.
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Figure 8. Mechanical properties of virus fibers. (Left) Effects of glutaraldehyde
concentration on the Young's modulus E shows a local minimum around 5%
glutaraldehyde. (Right) The variation of ultimate tensile strength o• with glutaraldehyde
concentration.
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Figure 9. Elongation of the virus fiber. Polarized optical microscopy (POM) images of
virus fibers (left) and schematic graphs of virus assemblies (right), where rods represent
individual virus particles constrained by crosslinks (in green). The virus fibers fabricated
from 0.5% (top) and 5% (bottom) glutaraldehyde solutions before stretching and after
manual elongation while drying.
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Figure 10. Comparison of bending and tension tests. (Left) Relationships of fiber
bending stiffness (P/d) to force application position (x+x') from vertical bending tests on
an oriented fiber (D = 65 ptm) and an unoriented fiber (D = 119 !tm) made from 0.5%
glutaraldehyde solution. (Right) Comparison of E for unoriented and oriented virus fibers
consisting of 0.5% glutaraldehyde solution under uniaxial tension test and cantilevered
bending test.
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Figure 11. Viscoelastic behavior
ultimate tensile strength Go as a
microscopy images of virus fiber
microscopy image (inset) of fracture
of virus fibers. (Left) Young's modulus E and
function of strain rate. (Right) Polarized optical
before and after fracture; and scanning electron
surface.
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Figure 12. Thermal degradation of virus fiber. Thermal gravimetric analysis responses
of pure and gold-coated virus fibers made from 2.5% glutaraldehyde solution. (Upper left)
Picture of virus fiber after heated up to 600 oC in air. (Upper right) Comparison of pure
and gold-coated virus fibers in nitrogen. (Bottom) Comparison of thermal degradations in
nitrogen and in air for pure (bottom left) and gold-coated (bottom right) virus fibers.
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Figure 13. Genetic information stored in virus fibers. Each virus fiber could have its
own genetic information based on the DNA stored in it. Lane I and 8 were 25 bp DNA
ladder. Lanes 2 to 4 were the PCR products of p8#9 virus fiber; lanes 5 to 7 were the
products of M13KE virus fiber; and lanes 9 to 11 were products of the virus fiber spun
from a mixture of p8#9 and M13KE clones. All samples were cloned using the same
universal primer, 1164Lprimer. 1339Rprimer was used for the samples loaded in lane 4,
7, and 11. #9Rprimer was used for the samples loaded in lane 2, 5, and 9. KERprimer
was used for the samples loaded in lane 3, 6, 10. From the electrophoresis results, each
types of virus fibers could be easily differentiated.
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..... GGTCGCGGATTTCGA
CACAATTTATCAGGCGAT
GATACAAATCTCCGTTGTA
CTTTGTTTCGCGCTTGGTA
TAATCGCTGGGGGTCAAA
GATGAGTGTTTTAGTGTAT
TCTTTTGCCTCT1TTCGTTT
TAGGTTGGTGCCTTCGTA
GTGGCATTACGTATTTTAC
CCGTTTAATGGAAACTTCC
TCATGAAAAAGTCTTTAGT
CCTCAAAGCCTCTGTAGC
CGTTGCTACCCTCGTTCC
GATGCTGTCTTTCGCTGC
AGTGTCGGGGTCGTCGC
CGGATTCGGATCCCGCAA
AAGCGGCCTTTAACTCCC
TGCAAGCCTCAGCGACCG
AATATATCGGTTATGCGTG
GGCGATGGTTGTTGTCAT
TGTCGGCGCAACTATCGG
TATCAAGCTGT
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Processing
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Figure 14. Genetically tunable functional fiber. Functionality-tunable fibers made
from M13 virus are mechanically comparable to synthetic homopolymer fibers. The
desired functionality can be programmed by manipulating the virus genome. The tunable
functionalities and mechanical properties of the virus fibers show the promise of various
applications.
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Chapter VI. Energy applications of virus-based materials
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VI.A. Summary
The conformation of the filamentous virus is a structure of interest for creating
high surface density materials. All the chemical or catalytic reactions happen at the
interfaces or surfaces of materials. The kinetic barrier of a chemical reaction is inversely
proportional to the surface density. In this chapter, the M I3 viruses served as filamentous
templates to form uniform nanowires, comprised of densely packed nanoparticles. The
electrochemical reaction of such nanostructure was studied to prove the concept
mentioned above. The electrochemically active materials synthesized using the viral
template showed relatively high reversible reactivities when compared to the active
materials made without the viral templates. This virus also provides flexible designing
capabilities to create hybrid nanomaterials, which may greatly improve the material
performances.
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VI. B. Introduction
Energy crisis
Energy crisis is an inevitable issue. Global energy consumption is projected to
increase by 54% over the next 25 years. In the United States, total energy consumption
increases more rapidly than domestic energy supply through 2025. Net imports of energy
are predicted to increase from 27% in 2003 to 38% in 2025 (Figure 1). The decline of
total domestic petroleum supply will speed up the increase of net imported energy.
Improvement of current energy supply system and development of new energy sources
are world-wide trends. In the human energy history, most of the energetic power
generated by human beings has brought a lot of containments and by-products which
have greatly changed the global environment. For example, the combustion of fossil fuels
in combustors to generate power emits carbon oxides (COx), sulfur oxides (SOx) and
nitrogen oxides (NOx), which cause green house effect, acid rain and air pollution.
Unlike the combustions, electrical power is the one which is clean and zero-emitting.
However, the processes to create electrical power may not be clean nor be efficient. Coal-
fired power plants, the main power plants using coal to generate electricity, emit
enormous polluted air as the combustors and are not efficient. Electricity generated by
nuclear fuel is efficient, but it generates radioactive waste which causes proliferation of
biological mutations and therefore requires long-term high level waste storage. Only few
energy sources to generate electricity such as solar, wind and hydroelectricity are
classified as "renewable energy", "green energy", or "'zero-emission energy". However,
these green energy sources are limited and not designed for portable usages in autos or
mobile electronics. Hence, electrochemical cells (or batteries) are designed to
accommodate the purpose of portable uses. Unlike the traditional combustors converting
fuels into heat and further converting heat into electricity, electrochemical cells directly
transform fuels into electricity. This mechanism greatly increases the efficiency of energy
usage and minimizes the loss of energy transformation, which makes electrochemical cell
an efficient power source. However, electrochemical cells may still cause environmental
pollutions. Primary batteries (e.g. zinc-carbon battery, alkaline-manganese battery)
require recycle system to avoid potential pollution to soil. Although secondary batteries
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such lead-acid battery (LAB), nickel-metal hydride battery (Ni-MH), and lithium battery
can be applied to cycle usages, the utilization of secondary batteries is still limited by
serving life, toxic contents and low capacity. The desire for clean and permanent energy
still urges scientists and engineers to exploit new power sources.
Fuel cell
In addition to the energy crisis and pollution issue, miniaturization of electronic
devices has become the need of the day owing to biological and medical applications
such as biosensors, pacemakers, and hearing aids. However, the development of small
power cells for these micro-devices is relatively slow. Although a lot of portable power
sources such as lithium ion batteries are available and wildly used in electronic devices,
the capability of these secondary batteries being used as implant power sources is
restricted to the external application because of the limited discharge time and the
possible leakage of toxic reactants stored in the electrodes. To fit in the strict
requirements of medical applications, a long-term power source using non-toxic fuels is
the ideal choice. In this category, fuel cells are the best of choices. Fuel cell can use non-
toxic reactants as fuels such as hydrogen and its byproducts are just pure water; therefore,
fuel cell has been classified as a "green energy". It keeps generating energy as long as the
reactants (or fuels) are continuously delivered into the cells. To date, the micro fuel cell
made by microelectromechanical system (MEMS) technology has been reported, but its
application to implanted electronic devices is still limited by the choice and storage of
fuels and the high working temperature.
Bio-fuel cell
Deriving from the concept of fuel cell, bio-fuel cells use the biomoleucles (such as
glucose) 99 in physiological environment as fuels and operate at physiological temperature.
It uses renewable fuel sources which are generated or recovered by biological
metabolisms and therefore provides electrical power eternally. Bio-fuel cell is an ideal
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power source to integrate artificial circuits or devices into metabolism cycles without
producing any harmful by-products. Redox-enzymes used in a bio-fuel cell can oxidize or
reduce specific biomolecules. A combination of oxidative enzyme on an anode, reductive
enzyme on a cathode, and electrolyte results in an electrochemical potential difference
between the anode and the cathode. Thus, a bio-fuel cell can generate electrical power at
physiological conditions. A schematic mechanism is depicted in (Figure 2). In this
example, glucose oxidase (GOx) is used as oxidative enzyme on the anode, and laccase
or cytochrome c/cytochrome oxidase (Cyt c/ Cox) is used as reductive enzyme on the
cathode. These bioelectrocatalytic electrodes oxidize glucose and reduce oxygen to
generate electricity. This power generation mechanism makes bio-fuel cell the best power
source for implanted devices. However, the practical application of bio-fuel cell to
implanted devices is still far to reach because of the lack of researches and techniques to
build efficient electron relays between enzymes and electron collectors. To date, the best
operation voltage and power density that have been reported to be suffice to drive silicon
integrated circuits are 0.78 V and 268 iW-cm - 2, but this bio-fuel cell lost 10% of its
power per day.100 Efficient electron relay, long-term enzyme stability, and high power
density are the key issues in improving the performance of bio-fuel cells.'0" ' 102 To
fabricate efficient enzymatic electrodes, it requires techniques to tailor molecular
structures at nanometric scale.
Surface density
To improve the power density of electrochemical cell, surface-volume ratios of
electrode materials is a main factor. In a solid state chemical reaction, the reaction rate is
determined by the interfacial surfaces among the reactants. The more the surface area is,
the less the kinetic limitation of reaction is. In terms of a tubular material, the higher the
aspect ratio (ratio of the length to the width) of this material is, the more the specific
surface area (ratio of surface area to volume) is (Figure 3). Therefore, nanomaterials,
such as nanotubes and nanowires, are very useful in promoting the efficiency of energy
usage. A material comprised of nanowires not only provides a high surface density but
also has structural stability, which can result from the structural supports of these
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nanowires themselves. Nanomaterials can store or generate energy more efficiently than
other materials of micro-scale structures. In other words, introducing well-tailored
nanomaterials into a electrochemical cell can greatly improve its power density.
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VI.C. Preliminary Experimental
VI.C.1 Biomineralization of cobalt oxide on virus
Materials. E4 virus contains tetra-glutamate preceded with an alanine on the N-
terminus of pVll proteins was engineered by Dr. Soo-Kwan Lee. Cobalt chloride
(CoC12-6H20) was purchased from Afla Aesar. NaBH 4 (sodium borohydride) was
purchased from Sigma-Aldrich.
Biomineralization of cobalt oxide nanowire. 100 pL of E4 virus (- 10' pfu/ gL) were
incubated in 1 mL aqueous cobalt chloride solution (1 mM) for 30 min at room
temperature to promote cobalt ion binding. Following reduction with I mL NaBH4 (5
mM) and spontaneous oxidation in water, monodisperse and crystalline cobalt oxide
(Co 304) nanowire were produced.
VI.C.2 Electrochemical analysis of cobalt oxide nanowires
Materials. Cobalt oxide nanowires made in VI.C.I., Super pTM (MMM Carbon),
poly(vinylidene fluoride)-hexafluoropropylene (PVDF-HFP), SwagelokTM design cells,
and separator CelgardTM 2400 were prepared.
Galvanostatic measurement. For electrochemical evaluation of the cobalt oxide
nanowires, cathode material was the mixture of 3.29 mg of the virus-based nanowires,
Super pTM (MMM Carbon) carbon black, and poly(vinylidene fluoride)-
hexafluoropropylene (PVDF-HFP) binder in a mass ratio of 74 : 15 : 11. The cathode
material was spread on copper foil, and Li metal foil was used as the anodic electrode.
The cathode and anode electrodes sandwiched a separator film of CelgardT" 2400 were
assembled into SwagelokTM design cell. The whole cell was saturated with the
electrolyte, 1M LiPF 6 in ethylene carbonate and dimethyl carbonate (1:1 by volume).
Galvanostatic cycle was performed between 3.0 V and 0.01 V using a MACCOR
automated tester.
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VI.C.3 Synthesis of iron phosphate virus fiber
Materials. M13 bacteriophage was amplified, purified and concentrated to 1013 pfu/pL.
The crosslinking agent (glutaraldehyde, 50%) was purchase from Sigma-Aldrich. Iron
phosphate powder (-1 Itm) was a gift from Nonglak Moothong in Prof. Yet-Ming
Chiang's group at M.I.T.
Fabrication of iron phosphate virus fiber. A mixture of bacteriophage suspension,
Super pTM carbon black, and iron phosphage in a mass ratio 75 : 20 : 5 was loaded into
the I mL syringe with gauge 31 needle. The spinning process was the same as
described in Chapter V. To test the electrochemical properties, the spun virus fiber
was deposited on an aluminum foil and assembled in a SwagelokTM design cell with a
Li metal foil as the anodic electrode and CelgardTM 2400 as the separator.
118
VI. D. Results and Discussion
Transition metallic ions are known to be chelated by electronegative atoms such
as nitrogen and oxygen in the ligands of molecules. Examples include, but not limits to,
ethylenediaminetetraacetic acid (EDTA), heme, and nickel (II) nitrilotriacetic acid
(NTA)....etc. The introduction of carboxylate ligands onto a surface theoretically will
enhance the number of metallic ions bound to the surface. Therefore, the goal was set to
create a peptide motif containing rich carboxylic groups on pVIII proteins to facilitate the
nucleation process on the filamentous virus by seeding metallic ions on the virus. One of
the successful engineering on the M13 bacteriopahge was the E4 clone. Tetra-glutamate
motif containing four successive glutamates (EEEE), termed E4, was fused to the N-
terminus of each copy of pVIII protein. The E4 virus was incubated with cobalt ions,
followed by reducing the cobalt ion with NaBH 4. The mineralized cobalt metal was
further oxidized in aqueous solution. The high resolution TEM (HR-TEM) electron
diffraction pattern and lattice spacing (Figure 4) confirmed that the crystal structure on
the virus template was Co304. Figure 4 inset showed that the measured lattice spacing
corresponds to the planes of Co30 4. Because pVllI proteins were genetically engineered
with high population of carboxylic groups and thousands of cobalt ions bound to the viral
surface could be reduced simultaneously, homogeneous and high crystalline
nanoparticles were densely grown on this viral template. Compared to the Au
nanoparticles grown in Chapter III, the crystal and grain structures of of the Co30 4
nanoparticles had totally different morphology, indicating different growing mechanisms.
In this case, the growth of Co30 4 nanoparticle on E4 virus was dominated by nucleation
process. Contrary to E4 virus, the wild type virus M13KE expressing no peptide insert or
the solution without virus formed irregular and large precipitates of Co/Co30 4 mixtures,
indicating the specificity of peptide binding/nucleating process.
The viral Co 30 4 nanowires had a large surface area of 141.7 m2/g as measured by
the Brunauer-Emmett-Teller (BET) method. The mass ratio of Co 30 4 and virus was
0.837 : 0.163 and the volume ratio of the virus compared to the Co 304 was estimated to
be 1.7 %. Voltage/capacity curves for the Co304 nanowires/Li half cell showed typical
lithiation/delithiation behaviors of Co30 4 materials. The larger first-insertion capacity
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compared to that in subsequent delithiation was characteristic of this material, and was
mainly due to irreversible reactions occurring upon initial lithiation. The estimated
lithiated state of LixCo30 4 was Lil.47Co30 4. Reversible capacity (Figure 5) ranging from
600 to 750 mAh/g was observed. The lithiation/delithiation capacity stabilized at 600
mAh/g over 20 cycles. The virus mediated the growth of uniform sized cobalt oxide
nanomaterials, maintained the structural integrity, and imparted dense materials packing
provided electrochemical advantages. Samples synthesized without the virus templates
exhibited rapidly fading capacity (Figure 5), which was most likely attributable to large
particle size, incomplete oxidation of cobalt, and inhomogeneous structure and
composition.
In the cycle use of the electrochemically active material, the lost of its capacity is
mostly attributed to the formation of non-conductive inert layers occurring in the
oxidation process. Therefore, introducing conductive metals into the active materials will
facilitate the electron dispersion and improve the capacity during the
charging/discharging cycles. However, depending on the types of electrolyte used in the
electrochemical cell, conductive metals will also lower the overpotentials required to
decompose the electrolytes. Fortunately, the electrolyte (LiPF 6, ethylene carbonate and
dimethyl carbonate) used here has relatively higher overpotential compared with the
operating/charging voltages performed by the viral Co30 4 nanowires/Li cell.
Due to the advantages could be brought by intruding conductive metals, a type
8+8 phage containing gold binding motif (p3-Aul2) and tetra-glutamate (E4) motif was
designed and produced using the methods described in the Chapter II. This virus was
named AuE4. The incubation of the AuE4 clones with 5 nm gold colloid suspension (as
described in Chapter III) also resulted in one dimensional arrays of Au nanoparticles.
Different clones such as wild type and E4 virus which do not have gold binding motif,
could not lead to the attachment of gold nanoparticles along the length of virus. After
removing unbound excess gold nanoparticles by centrifugation, Co30 4 was nucleated and
grown via the tetra-glutamate functionality, producing hybrid nanostructures of 5-nm Au
nanoparticles spatially interspersed within Co30 4 wires (Figure 6). The crystal structure
of Co30 4 was confirmed by electron diffraction, and inductively coupled plasma mass
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spectrometry (ICPMS) analysis indicated that Au nanoparticles were associated in Co 30 4
in a weight ratio of 2.4 : 97.6. The result, again, demonstrated the capability of viral
template for producing hybrid nanoarchitectures through genetic engineering.
The electrochemical property of the hybrid Au-Co 30 4 nanowire was evaluated
using galvanostatic cycling and cyclic voltammetry. The nanowires (-3.41 mg) were
deposited on the Cu substrate for the assembly of the electrochemical cell. Galvanostatic
measurement showed that the hybrid composite generated higher initial and reversible
lithiation capacity than the pure Co30 4 nanowires when tested at the same current rate
(Figure 7). The higher lithiation capacity might result either from the formation of Li-Au
intermetallic compound'0 3 or the conductive effects of Au nanoparticles on the reaction
of Li with Co30 4. However, the theoretical capacity of Au is approximately 408.2 to
136.1 mAh/g for the formation of LixAu (x = 1 to 3), which suggests a negligible
contribution to the lithiation capacity when considering the Au : C030 4 ratio (2.4 : 97.6)
as obtained above. Besides, when compared with the viral Co 304 nanowire, the cyclic
voltammogram of hybrid Au-Co30 4 nanowire (Figure 8) showed no significant new
redox peaks that could be associated with the lithiation of Au. °"3 This was the evidence to
improve the electronic conductivity upon the reduction of Co30 4 nanoparticles. The
incorporation of gold nanoparticles increased the lithiation rate (reduction) of Co30 4 as
indicated by the enhanced reduction peak seen by cyclic voltammetry in Figure 8, and the
specific capacity of the hybrid Au-Co30 4 nanowire was estimated to be - 30 % better
than that of the Co 30 4 nanowire (Figure 7).
The spinning of virus fiber can be designed into a roll-to-roll fabrication process
and the virus fiber can be continuously spun and produced. By integrating
electrochemical active materials with the virus, continuous fiber-based electrode was
fabricated. The virus-based electrode made by this process was flexible and could be
complied upon various substrate structures such as rod or film (Figure 9a and b). A
prototype of fibril electrode containing iron phosphate was spun and coiled upon an
aluminum rod and tested for electrochemical properties (Figure 9d and e). Galvanostatic
measurement was performed to test the lithiation capacity. The capacity was less than
10% of its theoretical capacity, and this might be due to the microphase separations of
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iron phosphate, carbon black, and engineered virus. The material compositions to spin
fibril electrode were not best tuned yet. More investigations are needed to optimize the
processing condition and electrochemical performance.
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IV. E. Conclusion
The cobalt oxide nanowires templated by M13 virus at room temperature
demonstrated comparable properties to nanoparticles fabricated at high temperature
(above 5000 C). The high aspect ratio structure of the M13 virus was proved to provide
advantages of creating high surface density of materials through homogenous nucleation
and stabilizing nanomaterials for electrochemical reaction. Fiber-based battery can be
designed using virus as the templating materials in the future (Figure 10). In addition, the
viral template was demonstrated to be a genetically tunable platform for creating hetero-
functionalities or hybrid materials. While more investigations on the effects of Au in
Co30 4 are required to reveal the exact electrochemical mechanism, the experimental
results has showed that a small amount of Au nanoparticles dispersed within Co30 4 to
produce a hybrid material markedly improved the electrochemical performance. Such
hybrid nanostructue showing the promise of improving electrochemical properties makes
the tunable M 13 bacteriophage a unique template for the convenience of designing other
potential hetero-materials.
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Figure 1 The trend of increasing energy consumption. (a) World marketed energy
consumption, 1970-2025. (b) Total energy consumption and production (quadrillion Btu)
in the US, 1970-2025 (Graph Source: Energy Information Administration, International
Energy Outlook 2004 and Annual Energy Outlook 2005).
124
IV. F. Figures
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Figure 2 A schematic representation of bio-fuel cell. In this bio-fuel cell, glucose
oxidase is used as the anode to oxidize glucose into gluconic acid and release electrons.
Reductive enzymes such laccase and cytochrome c/cytochrome oxidase complex can be
used as the cathode to reduce oxygen into water and complete the electrochemical cycle.
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Aspect
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Figure 3 Comparison of aspect ratio to surface area for tubular structures. Surface
density is the key parameter to affect the performance and life span of an energy material.
The higher the surface density, the better the overall performance.
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Figure 4. TEM images of virus templated Co30 4 nanowires. (Left and right) High-
resolution TEM images of Co30 4 viral nanowires. Electron diffraction pattern (inset,
upper right) confirmed that the crystal structure was Co30 4. The measured lattice spacing
corresponded to the planes of C030 4 . Magnified image (inset, lower right) shows the
lattice fringe of Co30 4 nanocrystals along the major coat pVIII proteins of a virus.
1 2 3 4 5
Cycle
6 7 8
Figure 5. Specific capacity versus cycle number. The capacity was calculated based on
the mass of C030 4 only. The data of virus templated nanowires and the powder that was
fabricated without viruses under the same condition was compared.
126
1600
1400
1200
1000
800
600
400
200
A
Q.E
(U
()
* U Charge
* Discharge
O
Virus templated
* Co3o, nanowire
8 Powder without virus
I 9 Q Q Q
- • • • m • •
I-
-
-
I-
a
Wl
Figure 6. TEM image of hybrid nanowires of Au nanoparticles/Co30 4. The gold
nanoparticles assembled in the hybrid nanowires were located at the center of the Co30 4
nanowires. The nanoparticles dispersed in the cobalt oxide materials could improve the
electrical performance of the active materials.
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Figure 7. Specific capacity of hybrid Au-Co30 4 nanowires. Half cell with Li electrode
was cycled at a rate of C/26.5. Virus mass was subtracted and the mass of active
materials such as Co30 4 and Au was counted. The capacity of virus-directing Co 30 4
nanowires without Au nanoparticles was compared with that of hybrid Au-Co 30 4
nanowires.
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Figure 8. Cyclic voltammograms of hybrid Au-Co 30 4 and C030 4 nanowires.
Approximately same quantities of active materials were compared. The cyclic
voltammetry was performed at a scanning rate of 0.3 mV/s. The electrochemical
performance was greatly improved when the gold nanoparticle was introduced.
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Figure 9 Fiber based lithium battery. (a, b) Virus based fibers containing iron
phosphate particles were spun and wrapped on an aluminum current collector. (c) A half-
cell was assembled with a lithium foil for electrical property measurements. (d) Specific
capacities of the virus based fiber discharged at three different rates. (e) Cyclic
voltammetry of FePO 4 virus fiber in the range of 2 to 4 V.
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Figure 10. Schematic design of uniaxial fiber-based battery. The center and outermost
layer are the current collectors. A layer of polyelectrolyte is coated between the anodic
and cathodic fibers.
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Remarks
The research presented here has expanded the applications of natural templates
for material syntheses and structural fabrications from nanometer scale to micrometer
scale. However, a lot still remains to be discovered and explored. The future studies
should focus on: 1) revealing the binding and growing mechanisms of materials
synthesized by the protein/peptide scaffolds; 2) developing new types of libraries based
on the engineering portions on the biological templates; 3) expanding the capabilities to
perform molecular expressions on the biological templates from small and single entities
(e.g. peptide) to large and multiple objects (e.g. enzyme). Continued efforts are needed to
establish complete techniques to fully control over the building blocks and manipulate
individual components at the molecular level. Undoubtedly, the fundamental studies of
peptide/protein materials and the driving forces of engineering applications eventually
need to be integrated to exploit the potentials of natural materials and to benefit the
world.
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